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Several bioaffinity assays are based on the detection of an analyte which is bound on a 
solid substrate via biochemical interaction. These so called solid-phase assays are 
based on the adhesion of the primary binding partner on a solid surface, which then 
binds the analyte to be detected. In this thesis work a novel solid phase based assay 
technology, known as spot technology, was developed. The spot technology is based 
on combination of high-capacity solid phases, concentrated in a spot format, utilising 
modified streptavidin molecules and recombinant antibody fragments. The reduction 
of the solid phase binding surface to a size of a spot enabled denser binding of the 
target molecules, providing improved signal intensities and signal-to-background ratio 
when applied in different solid-phase immunoassays. 
Streptavidin-biotin interactions are commonly utilised in numerous different bio-
affinity assays and the ultimate nature of streptavidin to bind biotin is among the 
strongest non-covalent interaction reported between two biomolecules. In this study 
native core streptavidin was chemically modified to provide polymerised streptavidin 
molecules with altered adsorption properties. These streptavidin conjugates, when 
coated onto polystyrene surface, provided enhanced biotin binding capacity and sur-
face stability when compared to a reference coating constructed with native strepta-
vidin. Furthermore, the combination of chemically modified streptavidin, site-
specifically biotinylated antibody fragments and the spot coating technology provided 
highly dense solid phase coating with improved binding properties. 
The performance of the spot assay technology was further demonstrated in different 
immunoassay configurations. Human thyroid stimulating hormone (TSH) and human 
cardiac troponin I (cTnI) were used as model analytes to show the applicability of the 
highly sensitive spot-based solid-phase immunoassay for detection of very low levels 
of analytes. It was demonstrated that the spot technology provided an assay concept 
with enhanced sensitivity and short turn-around times, characteristics that are highly 





ALP alkaline phosphatase 
Bio- refers to biotinylated molecule 
BSA bovine serum albumin 
cTnI cardiac troponin I 
DELFIA® dissociation-enhanced fluoro immuno-assay 
DL detection limit 
DTT dithiotreitol 
EDTA ethylenediaminetetraacetic acid 
ELISA enzyme-linked immunosorbent assay 
Eu europium 
Fab / Fab’ fragment antigen binding 
F(ab’)2 fragment of an antibody consisting two Fab fragments which are linked  
to each other with disulphide bridges at the hinge region 
Fc fragment crystallisable region 
Fd heavy chain portion of a Fab fragment 
GA-Sav glutaraldehyde modified streptavidin 
IEF isoelectric focusing 
IgG immunoglobulin G 
IgM immunoglobulin M 
K activity constant of a binding reaction 
Mab monoclonal antibody 
PAMAM olyamidoamine 
pI isoelectric point 
PSA prostate specific antigen 
UV ultraviolet 
SAM self-assembled monolayer 
SATA N-succinimidyl S-acetylthioacetate 
Sav streptavidin 
scFv single chain variable fragments of an antibody 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SH-Sav refers to SATA modified streptavidin or thiolated streptavidin 
SPI solid-phase immunoassay 
SPR surface plasmon resonance  
TCEP tris(2-carboxyethyl)phosphine 
TSH, hTSH (human) thyroid-stimulating hormone 
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1 REVIEW OF THE LITERATURE 
1.1 Introduction 
Immunoassay techniques utilising synthetic solid phases cover the majority of today’s 
modern assay designs. These solid-phase immunoassays (SPIs) are based on the bind-
ing of an analyte to a solid interface, thus providing a simple method for separating the 
reactive and non-reactive analyte in a sample solution (Butler JE, 2000). Immunoas-
says on solid phases have become routine techniques in a variety of areas in the medi-
cal science, including diagnostics, immunology and microbiology. In clinical diagnos-
tics these assays are widely applied to monitor the concentration of different bio-
chemical markers with altered expression in various pathophysiological conditions. 
Immunoassays can be divided into two main categories based on how the differentia-
tion between the reacted and non-reacted component is accomplished. In heterogene-
ous immunoassays the bound analyte is separated from the unbound counterpart by an 
additional washing and separation step while in homogeneous assay designs the im-
munoreaction occurs entirely in one interface, without a separation (Davies C, 2001, 
Hemmilä I, 1985). Most often the separation of bound and unbound component is 
accomplished through an interface by immobilising either one of the immunoreactant 
onto a solid surface. Thus, in some extent both heterogeneous immunoassays, like 
ELISA in microtitration well, and homogeneous immunoassays, like those utilising 
nanoparticles as solid phase (Kokko L, et al., 2004), can be considered as solid-phase 
assays. The homogeneous and heterogeneous assay types can be further characterised 
as competitive (reagent limited) or non-competitive (reagent excess) assays (Davies C, 
2001) (Figure 1). In competitive immunoassay the unlabelled analyte is competed with 
its labelled counterpart for the binding to the capture surface. The non-competitive 
assay utilises two antibodies, one bound to the solid phase and one carrying a detect-
able label, both binding to the analyte of interest. In principle, non-competitive sys-
tems are capable of yielding assay sensitivities order of magnitude greater than com-
petitive assay designs (Lövgren T, et al., 1990). 
The solid phase properties play a crucial role in both heterogeneous and homogeneous 
assay designs, conducted either in competitive or non-competitive manner. The SPIs 
on polystyrene have become the “assay of choice” over 30 years ago and already at 
that time (partially driven by straightforward adsorption of binding molecules) it was 
evidenced that passive adsorption of capture antibodies and other proteins on a solid 
surface results in molecular alteration, such as change in the three dimensional struc-
ture (Bull HB, 1956, Kochwa S, et al., 1967, Oreskes I, et al., 1961). In solid-phase 
assays, the chemical and physical properties of the solid phase itself as a binding sur-
face highly determine the assay functionality. 
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Figure 1. The basic principles of non-competitive (reagent excess) and competitive (reagent 
limited) heterogeneous immunoassays. In non-competitive immunoassays the fractional 
amount of antibodies that are occupied by the analyte is measured, thus reflecting directly the 
amount of analyte present in the sample. In competitive immunoassays the detectable signal is 
generated through those antibodies that are not occupied by the analyte, and thus the measured 
signals reflect indirectly the amount of analyte present in the sample. 
 
This review of the literature will concentrate on the physical and chemical properties 
of solid phase materials (particularly polystyrene) and discuss how these characteris-
tics affect on the solid-phase immunoassay performance. Furthermore, different im-
mobilisation methods to obtain a functional and well-oriented solid phase binding 
surface will be reviewed. 
1.2 Solid-phase immunoassay design 
The properties of the binding surface lay the initial foundation in solid-phase assay 
designs and heavily influence the results relating to the analytical sensitivity of the 
particular method. Thus, an important step in the solid-phase immunoassay develop-
ment is the selection of an appropriate solid phase material and the choice of the coat-
ing method that is to be applied to immobilise the capture agents to provide a fully 
functional capture layer. A multitude of different solid phase materials have been de-
veloped and utilised in numerous different applications. The quantitation of different 
biochemical markers by SPIs have been reported to be performed typically in plastic 
tubes, in microtitration wells, on spherical microparticles or on glass slides (Fenton JJ, 
YYYYYYYYYYYY YYYYYYYYYYYY YYYYYYYYYYYY
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et al., 1984, Hackler L, Jr., et al., 2003, Lövgren T, et al., 1996, von Lode P, et al., 
2003a). All these different assay approaches have different geometries and thus have 
unique physical dimensions as well as chemical properties, which makes the solid-
phase immunoassay highly adaptable technique providing variable assay characteris-
tics (in terms of binding kinetics, turn-around-times, processability). 
1.2.1 Sensitivity and detection limit 
Several authorities have given their own definitions for the term “sensitivity”, when 
applied in the analytical method’s performance. For example the international union of 
pure and applied chemistry (IUPAC) defines the sensitivity of an analytical system as 
the slope of the calibration curve or, if the curve is not a straight line, as the function 
of analyte concentration or amount (McNaught AD, et al., 1997). The international 
federation of clinical chemistry (IFCC) defines the assay sensitivity in terms of the 
detection limit (DL) relying on the general statement that the assay sensitivity is the 
smallest amount of the analyte that can be truly measured (Büttner J, et al., 1979). In 
addition, Ekins and co-workers have defined the assay sensitivity as “the resolving 
power of zero dose” proposing that maximal sensitivity can be achieved when the 
imprecision of the zero dose is least (Ekins R, et al., 1997). A widely accepted method 
to calculate the assay DL is based on the determination of the concentration reflecting 
the standard deviation of the zero-dose blank signal multiplied by three (ICH guidance 
for industry; Q2B Validation of analytical procedures: Methodology, 1996). This defi-
nition necessitates that the assay sensitivity can be improved, and thus reduced DL 
values can be obtained, by lowering the amount of non-specific binding. For example 
detergents (such as Tween 20 or Triton X-100) have been widely utilised to reduce the 
background signal caused by non-specific interactions between antibody and antigen 
adsorption in immunoassays (Engvall E, et al., 1972, Esser P, 1990). 
In every immunoassay, the overall performance of the method is influenced by the 
equilibrium constants of the binding reactions (i.e. the avidity of the antibody binding 
to the analyte), the signal measurement error, the accuracy of reactant addition and the 
extent of misclassification of the free labelled reactant as bound and vice versa (Jack-
son TM, et al., 1986). All of these directly affect to the assay sensitivity. For hetero-
geneous immunoassays the assay sensitivity is largely determined by the specific ac-
tivity of the label (Hemmilä I, et al., 1984, Jackson TM, et al., 1986). Different label-
ling techniques have been developed during the last few decades, radioisotopic tracers 
being the first label-molecules, that were adopted to immunoassays in 1960s (Yalow 
RS, et al., 1960). Since then also more specific nonisotopic labelling techniques have 
been employed, among which the fluorescent labels (such as lanthanide chelates), 
colorimetric substrates (such as alkaline phosphatase, ALP), and chemiluminescent 
labels have been the most widely exploited (Diamandis EP, 1990, Hemmilä I, et al., 
1984, Johannsson A, et al., 1986). Attachment of many signal generating groups to the 
labelling reagent (i.e. multilabelling) have been shown to improve the immunoassay 
sensitivity especially in time-resolved fluoroimmunoassays (Hemmilä I, 1985). 
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In addition to the above mentioned issues related to the assay components, the assay 
sensitivity can also be improved by careful design of the geometry of the assay reac-
tion compartment and the selection of the adequate measurement technology applied 
to the particular system. For example the detection limit of a time-resolved fluores-
cence immunoassay have been shown to improve through immobilisation of the cap-
ture agent within the area where the analyte captured on a solid surface coincides with 
the excitation beam of the detection signal on a U-shaped immunoassay well surface 
(Christopoulos TK, et al., 1990). Alternatively, microparticles in a form of magnetic 
beads, instead of planar surface, can be utilised as solid surfaces to enhance the assay 
sensitivity (Al-Abdulla IH, et al., 1989, Chapman RS, et al., 1982, Zhang H, et al., 
2006). Typically, these particles are made of polystyrene with an iron oxide core, hav-
ing functional groups on the particle outer surface to facilitate the biomolecule immo-
bilisation process. Since microparticles can be widely dispersed within the sample 
solution, the mass-transfer distance of the analyte and reagents to the immobilised 
antibodies is greatly reduced, which enables the antibody-analyte equilibrium state to 
be reached more rapidly than if the antibodies are immobilised on a planar surface. 
However, the use of microparticles requires highly integrated systems where the beads 
are collected with high efficiency after sequential equilibration and washing steps, and 
thus the usability of the particle based assays is somewhat limited. 
1.2.2 Coating density 
The importance of antibody orientation, both on planar surface and in terms of posi-
tion of binding sites is obvious to obtain maximum assay sensitivity. Coating density, 
meaning how the immobilised binding molecules are distributed over the coated sur-
face, is one of the most critical parameter when considering the solid phase properties 
affecting the solid-phase assay performance. Generally, the more capture molecules 
are adsorbed to the solid support, the more analyte molecules can be captured. The 
optimal adsorption density may thus correspond to the solid phase saturation. How-
ever, a very dense surface may not always be worth striven, because the optimal sur-
face density of a solid-phase assay also largely depends on the size of the captured 
analyte. For example, when considering a closest-packed monolayered surface pre-
pared from antibody Fab fragments, a surface coverage of 220-440 ng/mm2 have been 
reported, depending on the antibodies surface orientation (i.e. side, edge, or end-
orientation) (Buijs J, et al., 1995). However, if the dimensions of an antigen bound to 
such closely packed Fab surface is larger than the dimensions of an individual Fab 
bound to the solid phase, one antigen will cover more than one capture Fab, leading to 
decreased antigen binding efficiency (i.e. the percent of immobilised antibodies that 
bind antigen) (Brogan KL, et al., 2003), which may again limit the potential assay 
sensitivity. With very closely packed surface coverage the total surface binding capac-
ity easily falls down due to the repulsive intermolecular interactions between the cap-
tured molecules in near vicinity (Butler JE, et al., 1992, Norde W, 1986). 
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1.3 Solid phase materials and their chemical properties 
Coating of a biologically active molecule onto a solid surface plays an important role 
in diagnostics methodology. The primary surface properties (i.e. the chemical and 
physical properties of the synthetic solid surface) are critical for the assay performance 
of the surface-capture assays. Protein adsorption on the primary solid phase material is 
influenced by numerous different factors, including properties of the solid phase, such 
as surface roughness, hydrophobicity, charge, chemical composition, and structure. 
Furthermore, properties related to the protein itself, such as size, shape and charge, 
also affect to the efficiency of the overall coating process (Castner D, et al., 2002). 
The available material diversity provides possibility to apply numerous different im-
mobilisation techniques to the solid phase coatings, and this highly determines the 
selection of the most applicable surface material for the particular assay. Some of the 
widely used solid phase materials in SPIs are thermoplastics, such as polystyrene, 
polypropylene, polysulfone, or polycarbonate, which can be moulded into an unlim-
ited variety of shape (Mahajan S, et al., 2007, Penney CL, et al., 1989, Pesce AJ, et 
al., 1977, Young DB, et al., 1985). This formability enables the production of reaction 
compartments with different physical dimensions, thus providing different surface to 
volume ratios, which further influences the assay performance, especially the assay 
kinetics (i.e time in which the reaction equilibrium can be reached). This multiformity 
is realised when two different solid phase geometries, for example spherical micropar-
ticles and planar surface of a microtitration well and their functions in solid-phase 
immunoassays are compared. The reactive surface area of a microparticle is much 
larger than that of a microtitration well, leading to noticeable differences in the assay 
kinetics between these two assay types. Thus a careful consideration is to be made, not 
only on the immobilisation technique, but also on the primary selection of the syn-
thetic solid phase material (and dimensions) that is to be used for adsorption and im-
mobilisation of the capture agents, when developing new solid-phase assay systems. 
The chemical composition of a solid surface (i.e. the surface electronic nature) as well 
as the net charge of the protein to be coated plays an important role in the immobilisa-
tion efficiency of the solid phase coatings and the overall adsorption process. It has 
been generally observed, that the adsorption of a protein to a solid surface is at maxi-
mum at the pH close to the protein isoelectric point (Höök F, et al., 1998, Koutsoukos 
PG, et al., 1982). At pH below the pI value or pH above the pI value the protein sur-
face charge is increased, which causes repulsive electronic interactions between the 
protein and the charged solid surface (as well as between the neighbouring proteins) 
and thus decrease in the protein adsorption level is seen at these conditions (Norde W, 
1986). It has been further shown that the adsorption of proteins to a hydrophobic sur-
faces is dominated by hydrophobic bonding, whereas on a hydrophilic surface the 
electrostatic interactions are the main forces for protein adsorption (Buijs J, et al., 
1995). Bujis and coworkers (1995) found that at hydrophobic surfaces both IgG and 
F(ab’)2 fragments adsorb spontaneously, even when the protein net charge repel with 
the surface net charge. However, at hydrophilic surfaces the amount of protein ad-
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sorbed vanish completely under electrostatically repelling conditions, which indicate 
that the adsorption of proteins on a hydrophilic surface occurs only if there are enough 
charges on the protein surface that are attracted by charges on the solid phase. 
One of the most typical solid support material used in solid-phase immunoassays is 
polystyrene, which is hydrophobic in nature, when untreated. There are different ap-
proaches for immobilising biomolecules onto polystyrene, among which the passive 
adsorption and covalent coupling (when modified polystyrene material is used) are the 
most widely known. Polystyrene materials in the form of microtitraton wells are usu-
ally plasma-treated or gamma-irradiated, which reveal more hydrophilic groups and 
free radicals on the surface, providing improved surface capacity to adsorb proteins. 
The passive adsorption of a protein to a polystyrene is dominated by the intermolecu-
lar attraction forces, such as van der Waals forces (Esser P, 1997). In addition, the 
hydrophobic interactions and formation of hydrogen bonds between the adsorbed pro-
tein and the solid surface are utilised, thus favouring the hydrophilic chemical groups 
such as –OH, =O, –NH2, =NH, ≡N, found in the protein and surface, which are capable 
of participating the hydrogen bond formation. 
The covalent coupling of protein to the solid support minimises the leaching of the 
immobilised molecules from the surface, which is a generally recognised phenomenon 
for passive protein adsorption (Howell EE, et al., 1981). However, to achieve the co-
valent attachment of antibodies (or other proteins) onto a polystyrene surface, the 
polystyrene must first be chemically modified to provide suitable chemical groups. 
Primary amines are convenient groups for cross-linking of proteins, and several 
chemical or physical treatments to provide covalent linkage or coating of amine 
groups on the polystyrene surface have also been described in the literature. One 
method to provide amino-groups onto the polystyrene surface is by nitration with sul-
phuric acid and nitric acid, followed by reduction of the nitro groups (Page JD, et al., 
1998). Furthermore, direct graftin methods, like gamma irradiation (Varga JM, et al., 
1990), plasma treatment (Matson RS, et al., 1994), pre-coating with polymers such as 
phenylalanine-lysine copolymer (Karir T, et al., 2006), and electromagnetic irradiation 
(Elsner H, et al., 1989) are also some examples of methods that can be applied to in-
troduce reactive amine groups onto the polystyrene surface. These methods have been 
applied to produce functional binding solid surfaces useful for bioaffinity based solid-
phase assays. For example electromagnetic irradiation is used to functionalise a Co-
valinkTM NH surface, a commercial amine-containing polystyrene material manufac-
tured by NUNC A/S (Roskilde, Denmark) (Zammatteo N, et al., 1996). The Covalink 
polystyrene surface contains ten carbon length spacer arms carrying terminal amino 
groups which are free to react with active carboxylic or phosphate groups available in 
proteins or other biomolecules (Esser P, 1992a, Rasmussen S, 1990). 
Amine groups can be introduced also indirectly onto the polystyrene surface contain-
ing carboxyl, carbonyl or hydroxyl functional groups by means of water soluble car-
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bodiimide (Niveleau A, et al., 1993). Zammatteo et al (1996) reported a method for 
grafting secondary amines on polystyrene microtitration well surface by first carboxy-
lating the polystyrene surface with permanganate, followed by the activation of the 
carboxylic groups with water-soluble carbodiimide and finally coupling with secon-
dary amine (N-methyl-1,3-propane diamide). Furthermore, the amine groups gener-
ated onto a surface through different grafting methods can be cross-linked with poly-
ethylene glycol to introduce additional surface characteristics with respect of the bio-
molecule immobilisation (Sun X, et al., 2008). In addition also other methods that 
provide functionalised polystyrene surfaces capable for covalent attachment of bio-
molecules, have been reported and utilised in different assay setups. Among others, 
polyvinylbenzyl lactonoylamide (PVLA; poly[N-p-vinylbenzyl-4-Ο-β-D-
galactopyranosyl-D-gluconaminde), a polystyrene derivate with pendant lactonoyla-
mide chains (a material mainly utilised in coatings of cell culture dishes) has been 
used in covalent immobilisation of different proteins onto a microtitration plate sur-
face (Kang IK, et al., 2003, Kobayashi A, et al., 1992, Suzuki N, et al., 1997). 
1.4 Immobilisation techniques 
In addition to the direct adsorption of biomolecules to a synthetic solid surface, the 
immobilisation of the binding reagents on a bioactive secondary layer is commonly 
utilised in different solid-phase assays. Proteins can be immobilised on a solid support 
in many different ways. However, it is crucial that upon the immobilisation proteins 
retain their native conformational structure and, therefore, their bioactivity. Optimisa-
tion of immobilisation strategies for biomolecules is thus the key point to address be-
fore fully functional coatings can be prepared. Direct attachment of capture agents 
through passive adsorption would greatly simplify the immobilisation process, but 
may also suffer from several problems associated with e.g. surface stability. However, 
these methods are especially useful in applications where fast and inexpensive manu-
facturing process is necessary (e.g. one-use, disposable solid phases), providing a sim-
ple and fast immobilisation and patterning strategy. A variety of immobilisation meth-
ods based on different chemical cross-linking chemistries or protein attachment via 
special binding proteins have been developed (Turkova J, 1999). However, some im-
mobilisation strategies, like covalent attachment and cross-linking can suffer from 
problems, such as loss of bioactivity and thus result in reduced assay sensitivity in the 
solid-phase capture assays. 
1.4.1 Oriented versus random immobilisation 
Optimal immobilisation process involves attachment of capture molecules to the solid 
surface in a way that provides stable and oriented binding surface. When larger com-
plex molecules (e.g. antibodies) are passively coated on a solid surface, the orientation 
of the molecules will be random so that all of the adsorbed proteins will not be able to 
capture the analyte from the sample solution. Antibodies and other biologically active 
binding agents are conventionally adsorbed to the solid support by passive methods, 
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utilising primarily non-covalent interactions, such as hydrophobic forces and hydrogen 
bonds. This method provides antibody attachment on the binding surface in randomly 
oriented manner, resulting in high possibility of one or both of the antibody binding 
sites positioned in such a way that the binding of the antigen is sterically hindered. 
Despite the simplicity and speed of the passive adsorption technique, the analytical 
performance in immunoassays is quite poor. The lack of control over the orientation of 
the adsorbed binding molecule on the solid surface may lead to loss of binding activity 
and thus worsen the solid-phase assay performance. Butler et al (1993) reported that 
only 5 to 10 % of the adsorbed antibodies are found to be active after passive coating. 
The attachment of antibodies onto a solid support by physical adsorption can lead to 
partial or complete loss of the antigen binding activity as a result of several reasons: 1) 
antibodies are attached to the surface at a region close to the binding site and this 
causes a steric hindrance for the antigen binding, or 2) antibodies may subject to con-
formational changes and loose their activity during immobilisation or 3) multi-site 
attachment of the antibody to the solid support restrict the intramolecular flexibility of 
the antibody (van Erp R, et al., 1992). The immobilised solid phase capture antibodies 
may also have different physico-chemical and biological properties than in solution 
(Butler JE, et al., 1992). Furthermore, deposition of multilayers of the immobilised 
proteins, obtained after unspecific and random immobilisation, may increase the pro-
tein desorption from the coated surface and thus lead to unstable coating and irrepro-
ducible assay results. The loss of binding activity is not acceptable in many analytical 
systems, especially in those, which have limited surface area, including assays based 
on miniaturised systems integrated with microfluidics. 
If the immobilisation is done with a specific (site-selective) orientation, the binding 
regions of the antibodies (or other biomolecules) can be made readily accessible to 
antigens by directing the antigen binding sites upwards and away from the solid sup-
port. The molecular orientation of the adsorbed protein may be controlled to some 
extent by the buffer composition (i.e. buffer pH and ionic strength) and by the choice 
of the solid support material. For example, improved binding activity of the physically 
adsorbed monoclonal antibodies (Mabs) can be obtained by exposing the antibodies to 
a low pH environment prior to adsorption (van Erp R, et al., 1992). The acidic treat-
ment of Mabs changes the structural integrity facilitating an improved orientation of 
the molecule, meaning that the antigen binding region of Mab is more oriented to-
wards the solvent after acidic treatment, favouring antigen binding capacity. At higher 
ionic strengths the adsorption of proteins to the solid surface is usually enhanced, due 
to reduced lateral repulsion between the proteins (Buijs J, et al., 1995). 
A more precise orientation control (in addition to the buffer composition and selection 
of the solid support material) may be achieved by using covalent coupling through 
chemical linkages. The covalent immobilisation results in better assay reproducibility 
and stabilises the solid phase properties due to minimised desorption of the immobi-
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lised proteins from the solid surface, as compared to passive coatings (Howell EE, et 
al., 1981). The covalent attachment of protein to a solid support can be achieved using 
different conjugation chemistries and cross-linking reagents between the solid support 
and the biomolecule that is to be immobilised. For example antibodies possess several 
different functional groups that are readily suitable for modification or conjugation 
allowing site-oriented attachment of these molecules (Figure 2). 
Traditional covalent immobilisation methods between a biomolecule and a solid sur-
face utilise links to amino acid side chains of the biomolecules (O'Shannessy DJ, et 
al., 1987). One common method for covalent antibody coupling to the solid support is 
the utilisation of lysine ε-amine groups or N-terminal α-amine groups. In addition, 
carboxylate groups may be used for covalent coupling with another molecule using C-
terminal, aspartic acid, and glutamic acid residues. However, both amine and carboxyl 
groups are abundant in the antibodies (as well as they are in most proteins) thus fre-
quently providing non-oriented immobilisation if coupling techniques via amine and 
carboxylic groups are applied (Hermanson GT, 1996a). 
 
Figure 2. Schematic representation of antibody structure showing the functional groups that 
could be used to attach antibodies onto a surface. Primary amine groups (NH2) are found on 
lysine side-chains and at the amino terminus of each polypeptide chain. Sulphydryl groups (-
SH) can be generated by reducing disulphide bond in the hinge region. Carbohydrate residues 
containing cis-diols can be oxidised to create active aldehydes. Modified from Hermanson 
(1996a). 
 
Conjugation reactions are more successful to preserve the binding activity if the func-
tional groups that are utilised for conjugation are present in limiting quantities and 
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tional groups are the antibody hinge SH-groups, which can be produced by selective 
cleavage with a reductant, 2-mercaptoethylamine (DeSilva BS, et al., 1995). Alterna-
tively, smaller antigen binding fragments can be produced from antibodies through 
enzymatic digestion with for example pepsin or papain (generating F(ab’)2 fragment or 
Fab’ fragments) (Kurkela R, et al., 1988, Mariani M, et al., 1991). Both of these 
methods provide exposed sulphydryl groups in the protein structure that can be tar-
geted for conjugation using sulphydryl-reactive cross-linkers. 
Immobilisation of antibodies via sugar residues have also shown to provide functional 
well-oriented binding surface. Carbohydrate residues are largely located on the CH2 
domain of the Fc portion of an IgG molecule (Hermanson GT, 1996a) and only 10% 
of IgG have carbohydrate groups on their Fab’ fragments (Malan Borel I, et al., 1990). 
This finding has allowed the development of site-specific immobilisation techniques, 
that utilise either amine or hydrazide groups and aldehyde groups produced from oxi-
dizing oligosaccharide moieties (Batalla P, et al., 2008, Gering JP, et al., 2002). The 
only limitation of the carbohydrate mediated immobilisation techniques is that not all 
antibodies posses polysaccharides in their Fc-portion (Hermanson GT, 1996a, Malan 
Borel I, et al., 1990). 
A more sophisticated method to produce oriented immobilisation is the utilisation of 
different carrier molecules between the solid support and the primary binding mole-
cule on solid phase coatings. Several studies have reported enhanced surface binding 
capacity and surface stability when the capture molecules have been immobilised to 
the solid substrate through a carrier molecule. The coating through a secondary mole-
cule can serve as a spacer between the surface and the capture protein, thus providing 
a binding surface where the active binding agent can be located a distance away from 
the solid support. In this way denaturing effects evident for contacting with a synthetic 
support materials can be avoided. One example of such technique is the use of a more 
hydrophobic carrier protein (for example heat-treated BSA) to immobilise a less hy-
drophobic capture molecule (for example streptavidin) to a synthetic solid support 
(Tischer W, et al., 1991). Furthermore, König et al. (1998) reported the utilisation of 
human serum albumin coated micrtotitration plates, to which recombinant antibody 
fragments possessing a single albumin binding domain were further immobilised in 
site-oriented manner and utilised in an ELISA assay. 
Examples of assays that have gained improved characteristics through the oriented 
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1.4.2 Utilisation of streptavidin-biotin interaction 
Perhaps the most commonly utilised biochemical interaction for protein immobilisa-
tion is the interaction between streptavidin and biotin (Diamandis EP, et al., 1991, 
Schetters H, 1999). Streptavidin is a tetrameric protein which can bind simultaneously 
up to four biotins. Interaction between streptavidin and biotin is among the strongest 
biochemical interaction known today featuring an affinity constant (Ka) of 2.5 x 1013 
M-1 (Green NM, 1990). This ultimate binding characteristic have provided the possi-
bilities to apply streptavidin-biotin interactions in solid phase coatings, enabling ori-
ented and functional binding surfaces for solid-phase immunoassay applications. 
The immobilisation technique through the streptavidin- (or avidin-) biotin interaction 
is one of the most commonly utilised methods to obtain a solid phase binding surface 
where the capture agents are immobilised in an oriented way. The process in which 
one or more biotins are covalently coupled to a secondary molecule is called biotinyla-
tion. This coupling reaction results in biotin-containing molecules, which can be spe-
cifically coupled to streptavidin coated surfaces. Because of the small size of biotin 
(244 Da) it can be conjugated to many different biomolecules, such as proteins, carbo-
hydrates, lipid molecules and nucleic acids, without significantly altering the biologi-
cal activity of the target molecule (Della-Penna D, et al., 1986). 
The basic design of a biotinylation reagent (Figure 3) includes the bicyclic biotin ring 
at one end of the structure and a reactive functional group at the other end that can be 
used to attach the biotin to a secondary molecule (Hermanson GT, 1996c). There is a 
great variety of different biotinylation reagents available which can be used for modi-
fication of proteins and other biomolecules. In some applications, biotinylation re-
agents with extended spacer arms could potentially provide improved assay sensitiv-
ity. For example the binding site for biotin on avidin is located approximately 9 Å 
beneath the surface of the protein (Green NM, et al., 1971). 
 
Figure 3. The molecular structure of 
biotin and the basic design of a bioti-
nylation reagent. The biotinylation re-
agent includes the bicyclic ring structure 
and the valeric acid side chain of biotin 
in one end and a reactive group able to 
couple the target group at the other end. 
 
Biotin can be attached to antibodies through several different chemical groups (Table 2). 
The most frequently used biotinylation reagents react with the primary amines, such as 
α-amino groups of the N-terminal amino acids and aliphatic ε-amines of the amino acid 
Biotin
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lysine. Examples of such reagents are biotins containing NHS-esters able to react with 
the primary amino groups in proteins. Although the number and type of the functional 
groups available for conjugation can hardly be known, with most proteins it is, however, 
safe to assume that these primary amines are available and accessible for conjugation 
reactions. Lysines are usually present to some extent in proteins and are often quite 
abundant. For example tetrameric streptavidin contains up to 16 lysines (Gitlin G, et al., 
1988) whereas insulin contains only a single lysine (Sanger F, 1959). There is usually at 
least one α-amino acid in a protein, which is able to react with the NHS-ester of the 
biotinylation reagent. Although the N-terminal amines or lysines are almost always pre-
sent in a protein, and these groups are easily reacted, modification of proteins or other 
biomolecules with the amine-reactive biotin derivates is not always eligible, especially if 
site-specific biotinylation of the biomolecule is desired. 
Table 2. Examples of reaction chemistries for protein biotinylation. (Table is adapted from 
Avidin-biotin technology brochure, Pierce biotechnology Inc., 2003, USA).  
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Antibodies that possess reactive amine groups near to the antigen binding region, and 
thus are susceptible to loss of antigen binding activity when reacted with amine-
reactive biotin derivates, are preferably biotinylated with other biotin derivatives, such 
as those reacting with sulphydryl groups. In proteins, the amino acid cysteine contains 
free thiol group, which is generally the most reactive functional group in proteins 
(Brinkley M, 1992). In addition to the sulphydryl groups present in the amino acid 
cysteine residues, free sulphydryl groups can also be generated by reduction of disul-
phide linkages present in some biomolecules, using mild reducing conditions (Kar-
yakin AA, et al., 2000). Monoclonal antibodies can also be cleaved to smaller anti-
body fragments possessing free sulphydryl goups via enzymatic digestions to form 
(Fab’)2 fragments, which can then be further reduced to provide Fab’ fragments con-
taining free sulphydryl group at the cleaved hinge region. Furthermore, aldehyde reac-
tive biotinylation reagent can be utilised for antibody biotinylation if the carbohy-
drates of the antibodies are first oxidised with periodates. Because carbohydrates are 
selectively found in the Fc fragment of antibodies, the biotinylation is restricted from 
occurring near to the antigen binding region, thus providing possibility for site-
oriented attachment of these antibodies to a solid support through streptavidin-biotin 
linkage. (Hermanson GT, 1996b). 
1.4.3 Utilisation of antibody fragments 
Recombinant antibody technology has provided the possibility to synthesise antibody 
fragments with desired functionalities. The recombinant antibody production provides 
numerous advantages over the hybridoma methods, including increased diversity of 
specificities that are obtainable and greater speed of production without need to im-
munise animals. Over the last decades the N-nitrilotriacetic acid (NTA)/ His6-tag che-
lator system has become a powerful tool for the one step isolation and purification of 
gene products (Crowe J, et al., 1994, Hochuli E, et al., 1987). Furthermore the his-
tidine tag in a protein sequence can be utilised to provide site-specific attachment of 
other chemical groups which can be further applied for site-directed immobilisation of 
the protein to a solid support either directly or indirectly (Walter JG, et al., 2008). 
Many advantages are involved in the use of antibody fragments as solid phase capture 
agents, compared to intact antibodies. These advantages include diminished non-
specific binding and apparent low reactivity against heterophilic antibodies, as well as 
the ability to be immobilised in a more defined orientation (Bjerner J, et al., 2002, 
Warren DJ, et al., 2005, Väisänen V, et al., 2006). Assay systems that require high 
fractional activity and surface functional density have been shown to gain improved 
characteristics when utilising smaller antigen binding fragments, instead of full-size 
antibody, for capturing the analyte of interest. Peluso and coworkers (2003) have per-
formed an extensive study to investigate the influence of surface orientation and bind-
ing density of the capture layer to the assay characteristics in a microarray system. 
They found that oriented immobilisation of Fab fragments enabled increased antigen 
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capturing, compared to an oriented Mab surface, providing three fold improvement in 
the detected signal intensities in a fluorescence based immuno-sandwich assay. 
1.4.4 Utilisation of antibody binding proteins 
One method to produce a properly oriented antibody immobilisation on a solid surface 
is the utilisation of selective binding proteins, e.g. protein A or protein G, which bind 
to the heavy chain constant Fc region of antibodies. Protein A is a 42 kDa protein 
found in the cell wall of Staphylococcus aureus. It contains five highly homologous 
Fc-binding regions having high affinity (Kd ≈ 10-8 M) for the Fc-regions of immu-
noglobulins from various species (Aybay C, 2003, Goding JW, 1978). The principal 
molecule that can be bound is IgG, although the classical Fc-binding capability of the 
protein A is restricted to certain IgG subclasses only (subclasses 1, 2 and 4) (Björck L, 
et al., 1984). In addition to the Fc-selectivity, protein A is also able to bind the Fab-
fragment of human IgM (Aybay C, 2003). Protein G, found in the surface of strepto-
coccal cell, contains three highly similar amino acid regions that are capable of bind-
ing the Fc-region as well as the Fab portions of IgG molecules from various species 
(Nomellini JF, et al., 2007). Antibodies from different species (including human, 
mouse, rat, bovine, sheep, goat and horse) and subclasses that do not well bind to pro-
tein A generally bind to protein G. 
Several studies have reported successful antibody immobilisation by using protein A 
or protein G layers on a solid surface. For example Lee et al. (2007) reported a well 
oriented protein G film on a gold surface utilising genetically engineered protein G, 
that contained cysteine residues able to react with the gold surface. When the surface 
functionality of the cysteine-tagged protein G was compared with a tag-free protein G, 
it was revealed that approximately 4-fold more human IgG was able to bind to the 
cysteine-tagged protein G layer compared to the reference tag-free protein G layer. 
The improved antibody binding capacity of the cysteine-tagged protein G layer was 
resulted from the formation of a well-oriented binding surface on the gold surface. 
Utilisation of protein A as capture linkage in solid-phase assays has been reported for 
example by Marquette et al. (2008) and Renberg et al. (2005). 
1.4.5 Self-assembly and self-assembled monolayers 
One embodiment of the self-assembly process is the formation of so called self-
assembled monolayers (SAMs), which are “thin ordered assemblies that are formed 
spontaneously by the adsorption of a surfactant with a specific activity of its head 
group to the substrate” (Schreiber F, 2000). Self-assembly, in general, is a spontane-
ous and reversible organisation of molecular units into ordered structure by non-
covalent interactions. The primary driving force for the self-assembly process is phy-
sisorption, i.e. the adsorption energy generated from weak hydrogen bonds and van 
der Waals interactions (Churbanova IY, et al., 2006, Khatri OP, et al., 2008). Self-
assembly is a common phenomenon in nature and it is exhibited in the formation of 
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lipid membranes, in DNA double helixes and in the proteins quaternary structures, 
thus being crucial to the cell function. Another common example of self-assembly 
process is the formation of micelles by surfactant molecules, a phenomenon closely 
related to the cleaning action of soap. Self-assembly has been used in numerous dif-
ferent industrial and technical applications, such as in the production of dendrimeric 
particles generated by self-assembly of smaller subunits to larger structures. Den-
drimers are spheroid or globular nanostructures that are precisely engineered to carry 
molecules encapsulated in their interior void spaces or attached to the surface (Mat-
thews OA, et al., 1998). Size, shape, and reactivity of the dendrimeric structures are 
determined by generation (shells) and chemical composition of the core, interior 
branching, and surface functionalities. In addition to the control over size, shape and 
surface functionality, their physical and chemical properties, such as high solubility, 
high surface density and high affinity, makes the dendrimeric molecules highly appli-
cable to a variety of analytical systems, including immunoassays (Klajnert B, et al., 
2001). Highly effective immunoassays, based on antibodies covalently attached to 
fifth generation PAMAM dendrimers have been reported by Singh and co-workers 
(Singh P, et al., 1996, Singh P, et al., 1994). 
SAMs were first discovered by Bigelow et al. (1948) who noticed that eicosyl alcohol 
was able to adsorb from a solution to the interior walls of an Erlenmeyer flask. In that 
time they reported first time the formation of monomolecular coatings by self-
assembly of surfactants onto platinum support. Because of the ease of preparation, 
good orientation and high stability of the SAMs, they have been utilised in various 
different technical applications. One classical examples of SAMs is the assembly of 
thiols on gold surface (Karyakin AA, et al., 2000). The utilisation of SH-group con-
taining antibody fragments on a gold surface to provide a functional solid phase has 
been reported by several groups. Karyakin et al. (2000) used native immunoglobulin 
thiol groups, liberated through splitting the intact antibody into two half-IgG frag-
ments, for simple adsorption onto a gold support to generate a functional solid phase 
for bioaffinity assay. This approach can be utilised generally with all immunoglobu-
lins. Zhang et al. (2006) used gold-coated magnetic particles coated with thiol-
containing antibody Fab fragments. The attachment of the thiol containing Fab frag-
ments by self-assembly onto a gold surface provided enhanced binding efficiency and 
analytical performance of a solid-phase immunoassay: a 2–fold improvement in the 
dose-response slope, enabling up to 13-fold improvement in the detection limit of the 
particular assay setup was reported. In addition, an engineered cysteine containing B-
domain of Staphylococcal protein A has been utilised to provide an oriented immobili-
sation by the self-assembly process on a gold surface (Kanno S, et al., 2000). It has 
been also shown that thiolated protein G, when immobilised to a gold electrode, pro-
vides faster antibody immobilisation and improved orientation for the analyte binding, 
compared to a conventional covalently bound nonthiolated protein G surface on an 
alkanethiol coated gold electrode (Fowler JM, et al., 2007).  
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The most widely utilised biotechnical applications of SAMs are the usage of such 
coatings in surface plasmon resonance (SPR) and in lab-on-chip devices, where they 
have gained numerous advantages for the assay performance. Gobi et al. (2007) re-
ported enhanced sensitivity and surface stability on SAM-based SPR immunosensor 
for the detection of a small molecular weight compound, benzaldehyde. Also other 
groups have reported improved surface functionality when SAM based SPR surfaces 
have been compared with surfaces prepared by covalent coupling methods (Sigal GB, 
et al., 1996). In addition to the immunoassay applications, SAMs on SPR have been 
widely used to study the adsorption properties of biomolecules to organic surfaces 
(Prime K, et al., 1991). 
Self-assembly peptides are one example of self-assembling biomolecular materials 
that can be utilised in the modification of surface properties. Ionic-complementary 
peptides have a unique molecular structure of alternating positive and negative charge 
distributions, thus leading to ionic-complementarity. The amphiphilic nature of the 
ionic-complementary peptides allows them to interact with both hydrophobic and hy-
drophilic surfaces, which is advantageous for different surface modification applica-
tions. In addition to the hydrogen bonding and hydrophobicity, these peptides contrib-
ute to the peptide self-assembly (Yang H, et al., 2007). The self-assembly process is 
highly dependent on the pH of the solution, and thus by simple adjustment of the solu-
tion pH the charge state of the peptides can be altered leading to altered interaction 
with the surface and peptide, providing excellent chemical stability. Self-assembling 
peptides have been found to be very stable over a wide range of pHs, at high tempera-
ture and in the presence of denaturing agents and proteases (Zhang S, et al., 1993, 
Zhang S, et al., 1994). Furthermore, the peptide sequence can be designed and synthe-
sised to contain desirable functions, such as residues containing COOH or NH2 groups 
for protein binding, which provides further advantages for their usage in the surface 
modification purposes (Shervedani RK, et al., 2006, Zhang S, et al., 2005). 
Another example of surface active self-assembly proteins applicable for solid-phase 
assays, is fungal hydrophobins. The high surface activity and the characteristic prop-
erty of hydrophobins to form an amphipathic membrane upon contact with a hydro-
philic-hydrophobic interface allow them to change the nature of a surface. These 
properties make hydrophobins potential tools in many biotechnological applications. 
For instance, hydrophobins have been utilised as priming layers to attach proteins to 
hydrophobic surfaces, such as silanized glass or Teflon (Linder M, et al., 2002). In 
addition, variety of proteins, such as antibodies or enzymes, can be immobilised to a 
solid supports using hydrophobin-protein fusions, allowing high concentration and 
ordered packing of the protein of interest (Linder MB, et al., 2005). 
1.5 Miniaturised assay systems 
The development of non-radioactive, highly specific labels in the 20th century enabled 
the immunoassays to become more sensitive and turned the interest of immunoassay 
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designs towards miniaturised, multi-analyte assay concepts. The miniaturisation of the 
assay designs offers many practical possibilities to develop functional point-of-care 
devices especially for assays where the measurement of at least two analytes is clini-
cally desirable (for example in thyroid disease), offering reduced sample volumes and 
running costs. One example of miniaturised assay technology is microarrays, which 
have been utilised in numerous different formats ranging from arrays of a few ele-
ments (Mendoza LG, et al., 1999) to high density arrays (MacBeath G, et al., 2000). 
Despite the advantages related to the reaction volume, and possibilities for automation 
and parallelisation, the miniaturised assay system has also its limitations contributing 
mostly to the surface functionality. 
1.5.1 Ambient analyte theory 
The first truly highly sensitive miniaturised assay concept was represented by Ekins 
and coworkers (Ekins R, et al., 1992, Ekins R, et al., 1990, Ekins RP, 1989). This so 
called ambient analyte immunoassay is an assay system that measures the analyte 
concentration in the sample solution in ambient analyte condition, i.e. in conditions 
where the amount of the analyte is not a limiting factor. When an antibody is intro-
duced to a sample medium containing the analyte, the binding sites of the antibody are 
occupied by the analyte to a fractional extent that reflects both the binding reaction 
equilibrium and the final analyte concentration that is unbound in the sample mixture. 
Generally the final concentration of the free analyte is dependent both on the concen-
tration of the capture antibody and the concentration of total analyte present in the 
sample. However, when the capture antibody concentration in the assay system is less 
than 0.01/K (where K is the activity constant of the binding reaction) the resulting 
“fractional” occupancy of the antibody binding sites reflects only the ambient analyte 
concentrations in the medium and is thus independent of the total antibody present. 
Thus the ambient analyte assay theory demonstrates that miniaturised ligand-binding 
assays are able to achieve a superior sensitivity. 
1.5.2 Microarray technology 
Microarray systems consist of a large number of regularly arranged discrete spots (< 
250 µm in size) of capture molecules, which are transferred onto a solid substrate us-
ing spotting robots (Glökler J, et al., 2003). Depending on the assay application, dif-
ferent capture molecules, such as antibodies (Haab BB, et al., 2001), DNA (Wacker R, 
et al., 2004), peptides (Min DH, et al., 2004) or aptamers (Lee M, et al., 2000) can be 
used. One crucial factor in the generation of microarrays for different purposes is the 
choice of the surface coating used for immobilisation of the capture agents (Kersten B, 
et al., 2005). The extent and kind of interaction evolved between surface and the cap-
ture agent differs widely between molecules and therefore, achieving a low degree of 
unspecific binding is extremely complicated in microarrays, where usually a complex 
sample containing thousands of molecules is to be analysed. 
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The solid support material used in the generation of microarrays must provide optimal 
binding conditions and an environment that promotes functionality of the immobilised 
substances. In addition to the thermoplastic materials (like polystyrene), used in the 
conventional solid phase assay coatings, several other materials are more favoured in 
the microarray production. Silica is the most often used material in microarrays, since 
it has great chemical resistance against solvents, it is mechanically stable and it has 
low intrinsic fluorescence properties (Benters R, et al., 2001). Additionally, the sur-
face silanol groups of silica are sufficiently reactive to allow covalent modifications 
(Afanassiev V, et al., 2000, Beier M, et al., 1999). However, a general drawback on 
the silica supports is frequently poor surface coverage resulting limited immobilisation 
capacity and relative low assay sensitivity (Afanassiev V, et al., 2000). The different 
support medias that have been utilised in the production of microarray immunoassays 
have been recently reviewed by Kusnezow and Hoheisel (Kusnezow W, et al., 2003). 
 
Aims of the study 
 28
2 AIMS OF THE STUDY 
The main objective of this thesis work was to establish a new assay technology for 
solid-phase immunoassays and by this technology to improve the characteristics of 
solid-phase immunoassays utilising novel binding surfaces. 
More specifically the aims were: 
I. To establish and evaluate a new spot assay technology and its potential, using 
mini wells with different spot dimensions and solid phase coating chemistries 
based on streptavidin-mediated immobilisation. 
II. To further evaluate the spot assay technology and its applicability to a novel 
immunoassay utilising site-oriented attachment of the capture agents to provide 
highly dense binding surface for analyte capturing. Furthermore the importance 
of the utilisation of several capture antibodies was investigated. 
III. To disclose the properties of a chemically polymerised streptavidin and demon-
strate its ability to improve surface stability and biotin binding capacity com-
pared to a native streptavidin surface when coated on a solid support. 
IV. To investigate potentials of another patterning approach for spot-shaped binding 
surface production, utilising contact printing technique in combination with 
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3 SUMMARY OF MATERIALS AND METHODS 
A detailed description of the materials and methods are presented in the original pub-
lications I-IV. A brief summary and some additional information is presented in the 
following chapters. 
3.1 Preparation and characterisation of chemically modified streptavidin 
Native streptavidin (Sav) and chemically modified streptavidin were used in solid 
phase coatings. Amine-reactive glutaraldehyde (I) and N-succinimidyl S-
acetylthioacetate (III, IV) were used to cross-link streptavidin molecules to form larger 
protein conjugates. The characterisation of the modified streptavidin was performed 
using size-exclusion chromatography, SDS-PAGE and isoelectric focusing. 
3.1.1 Cross-linking chemistries (I, III, IV) 
The bis-aldehyde homobifunctional cross-linking compound glutaraldehyde (from J.T 
Baker, Deventer, The Netherlands) was used to conjugate the individual streptavidin 
units into larger protein polymers. The conjugation of streptavidin molecules was per-
formed according to Välimaa et al. (2003) and it briefly contained the following steps: 
prior to conjugation lyophilised streptavidin was dissolved in pure water. A reaction 
mixture containing 2 mg/ml Sav, 10 mM NaH2PO4/ Na2HPO4 (pH 7.0), 150 mM NaCl 
and 1.0 % glutaraldehyde was prepared followed by incubation at + 4 oC for 2 hours. 
The excess of glutaraldehyde was removed by eluting the reaction mixture in TSA 
buffer (50 mM Tris-HCl pH 7.75, 150 mM NaCl, 0.05 % NaN3,) through NAP-5 and 
NAP-10 desalting columns (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The 
molecular concentration of the purified glutaraldehyde cross-linked streptavidin (GA-
Sav) was determined by measuring absorbance at 280 nm or alternatively with a dye-
binding assay (Micro BCA assay from Pierce Biotechnology). 
To introduce sulphydryl residues (thiolation) to Sav molecules, streptavidin was treated 
with amine reactive N-succinimidyl S-acetylthioacetate (SATA, from Pierce, USA) as 
described in III. Briefly, streptavidin was first dissolved in pure water and diluted further 
in phosphate buffer (pH 7.5) to obtain a final streptavidin concentration of 37-148 µM 
(1-4 mg/ml) in the solution. Various molar excesses (5-, 20-, 40-, 60- and 80-fold) of 
SATA over Sav were used to optimise the cross-linking reaction of the native strepta-
vidin to form larger protein conjugates. After the reaction at room temperature the pro-
tected sulphydryl groups that were bound to streptavidin were de-protected with hydro-
xylamine. The final reaction product containing the cross-linked streptavidin (referred as 
SH-Sav or thiolated streptavidin) was purified through desalting column and eluted in 
borate buffer (pH 8.3) containing EDTA. The incorporated thiol groups were monitored 
with Ellman’s reaction (Ellman GL, 1959, Riener CK, et al., 2002) and the protein con-
centration of the purified SH-Sav was determined through measuring absorbance at 280 
nm. More specific characterisation of the SH-Sav was done using chromatographic and 
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electrophoresis techniques. The chemical characterisation of GA-Sav has been previ-
ously reported elsewhere (Välimaa L, et al., 2003).  
3.1.2 Characterisations of modified streptavidin (III) 
Size-exclusion chromatography 
To determine the polymerisation levels of the thiolated cross-linked streptavidin (SH-
Sav) and to monitor the chemical stability of the conjugates, size-exclusion chroma-
tography on Superose 200 HR 10/30 column using Äkta explorer system (both from 
GE Healthcare Bio-Sciences AB) was performed. Basic buffers, such as Tris-HCl or 
borate buffers with pH 8.4-8.8, were used for the isocratic elution of the streptavidin 
from the size-exclusion column. The size-exclusion chromatography analyses were 
monitored by measuring absorbance at 280 nm. 
SDS-PAGE and IEF 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) in reduc-
ing and non-reducing conditions was run to determine the molecular weight of the 
polymerised SH-Sav molecules. SH-Sav and the reference native streptavidin (∼1 
mg/ml) was diluted in buffers containing 50 mM Tris-HCl (pH 8.0), 5 mM EDTA, 
12.5 % SDS, 0.05 % bromofenol blue and, when reducing conditions were used, addi-
tional 25 % β-mercaptoethanol. The SDS-PAGE analyses were run using PhastGel 4-
15 and PhastGel 8-25 gradient gels (GE Healthcare Bio-Sciences AB) in PhastSys-
temTM electrophoresis device (GE Healthcare Bio-Sciences AB). The proteins were 
visualised in the gel using the silver staining program for SDS-PAGE analysis. 
The pI values of SH-Sav were determined for SH-Sav molecules treated with different 
molar excesses (5-, 20-, 40 and 80-fold) of SATA. To determine the pI values of the 
SH-Sav by isoelectric focusing (IEF), reference native streptavidin and SH-Sav mole-
cules were first diluted in the sample buffer in the concentration of 1 – 3 mg/ml and 
analysed on PhastGel IEF 3-9 gradient gel using PhastSystemTM electrophoresis appa-
ratus. The proteins were visualized in the gels using the IEF silver staining program. 
3.2 Design and manufacturing of the spot-shaped solid phases 
During this thesis study more detailed optimisation of the composition of the coating 
solution for spot coatings was performed to provide a functional and stable strepta-
vidin coating with improved biotin binding properties. The conventional microtitration 
wells coated with streptavidin or with chemically modified streptavidins (GA-Sav or 
SH-Sav) were used as reference surfaces throughout the studies. 
Modified immunoassay wells (spot wells), containing a small circular indentation 
(“mini well”) of either 2.5 mm, 3.4 mm or 4.5 mm in diameter and approximately 
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0.2 mm in depth, moulded in a bottom of a conventional single microtitration well, 
were served as solid supports for optimising the coating chemistries and the spot as-
says (I, II). The purpose of the indentation was to give physical boundaries for liquid 
droplet used for coatings to produce a spot-shape binding surface for analyte capture 
in solid-phase immunoassays (Figure 4). The wells were manufactured in collabora-
tion with NUNC A/S (Roskilde, Denmark) and were made from low-background fluo-
rescent polystyrene, irradiated to obtain the maximal protein adsorption capability. 
Figure 4. Spot well designs. Spot wells containing moulded spot areas with different sizes. In 
each well the hollow of the spot is 0.2 mm in depth. The diameters of the moulded spots are 
2.5 mm, 3.5 mm or 4.5 mm, corresponding to total binding areas of 4.91 mm2, 9.62 mm2 and 
15.90 mm2, respectively. Respective surface areas including the bottom and the walls of the 
mini wells are 6.5 mm2, 12 mm2 and 19 mm2. 
 
In addition to the moulded spot wells (mini wells) described above, special spot wells 
possessing the spot-shaped binding area in the bottom of conventional microtitration 
wells (Maxisorp microtitration wells in single well format, from NUNC A/S) were 
produced with contact printing technique (Flexys device from Genomic SolutionsTM, 
USA) utilising solid pins (IV). This technique enabled the production of spot-shaped 
binding surfaces without physical indentations and provided faster coating processes 
originated from reduced droplet volumes. 
3.2.1 Coating of conventional microtitration wells (I-IV) 
Conventional polystyrene microtitration wells in single-well format or in C12 plate-
format were coated with native streptavidin or with cross-linked streptavidins (III, IV). 
In addition to the wells coated in-house, commercial streptavidin coated plates (manu-
Eu
EuEuEu
∅ = 2.5 mm
A = 4.91 mm2
∅ = 3.5 mm
A = 9.61 mm2
∅ = 4.5 mm
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factured by Innotrac Diagnostics Oy, Finland) were used (I, II). In general, the coating 
procedure included the following steps: first streptavidin was diluted in selected coat-
ing buffer to given protein concentration. Buffered solutions with pH 5 – 8 were used. 
A volume of 200 µl of the coating solution was applied to each of the wells and the 
coating was performed over night incubation at + 37 oC. In some cases the coating 
solution was allowed to dry during the coating process (IV). After over night incuba-
tion the wells were washed with the washing solution containing additional 0.05 g/l 
Tween 20. The uncoated regions were blocked with BSA during over night saturation 
at room temperature. Finally the dried wells were used directly or packed in closed 
chambers with desiccant and stored at 4 oC. 
3.2.2 Coating of the spot wells (I, II, IV, unpublished) 
Spot wells (mini wells) with circular indentations of 2.5 mm, 3.5 mm or 4.5 mm in di-
ameter, were coated with Sav (I, II), GA-Sav (I), or SH-Sav (unpublished) using coating 
buffer (pH 5.0) containing 20 µg/ml of the protein. The coating volumes applied to the 
spot wells were 4 µl, 10 µl and 15 µl for 2.5 mm, 3.5 mm and 4.5 mm spots, respec-
tively. Coatings were performed as over night incubation at 35 oC in closed humid 
chambers to prevent evaporation of the small droplets. After overnight incubation the 
spot wells were washed and incubated with 100 µl of saturation solution containing 
BSA. After saturation the wells were allowed to dry before use. Wells that were not used 
immediately were packed in closed containers with desiccant and storage at 4 oC. 
Spot-shaped binding surfaces into the regular microtitration wells (IV) were manufac-
tured using Flexys device (Genomic Solutions, USA) utilising contact printing tech-
nique. Coating buffer containing 1.5 mg/ml of SH-Sav or 10 mg/ml of Sav diluted in 
100 mM Na2HPO4, 50 mM citric acid and 0.5 M betaine monohydrate was used. The 
printing was performed with solid pins (manufactured in collaboration with Innotrac 
Diagnostics Oy, Turku, Finland) having a diameter of 2.0 mm, which provided a pat-
terned circular spot-shaped binding area of approximately 4.2 mm2 (and 2.3 mm in 
diameter) in the bottom of a polystyrene microtitration well (Maxisorp). Before and 
after each printing action, the solid pins were washed with water by dipping the pins in 
ultrasonic bath for 10 seconds and rinsed with 20 % ethanol and finally dried using the 
specific washing and drying unit incorporated in the Flexys device. After printing the 
surfaces, the created spots were allowed to dry 5 to 24 hours at 35 oC, followed by a 
saturation step and final washing with the wash solution and drying. The contact print-
ing process described above was also utilised to coat the spot wells with antibodies or 
antibody fragments (IV). 
3.3 Biotinylation and labelling with fluorescent labels 
3.3.1 Biotinylation of monoclonal antibodies (I-IV) 
Biotinylation of monoclonal antibodies anti-hTSH Mab 5404 (Medix Biochemica, 
Finland) (I), anti-cTnI Mab 7F4 (Hytest Ltd., Finland) (II), anti cTnI Mab 4C2 (Hytest 
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Ltd.) (II) and anti-cTnI Mab 19C7 (Hytest Ltd.) (II), were performed using isothiocy-
anate modified biotin (Mukkala V-M, et al., 1993). Anti-hTSH Mab was labelled with 
40-fold molar excess (147 µM) of biotin over the antibody in a sodium carbonate 
buffer (pH 9.8). To ensure sufficient remaining affinity of the cTnI specific antibodies, 
the biotinylation of these was performed with lower proportional molar excess of bio-
tin over the antibodies. A molar excess of 10-fold (75 – 145 µM) of biotin over the 
cTnI specific antibodies were used for biotinylation in a sodium carbonate buffer (pH 
9.8). After four hours of incubation each of the biotinylation reactions were reduced in 
volume by ultrafiltration through a 50 kDa cut-off membrane and purified through two 
consecutive desalting columns. 
The portion of biotinylated antibodies was determined using an in-house test per-
formed as follows: first biotinylated antibody was diluted in assay buffer (Assay solu-
tion, red, Innotrac Diagnostics) to the concentration of 2 ng/µl and applied to the strep-
tavidin coated plates as a volume of 200 µl/well. After one hour incubation with shak-
ing a portion of this solution was transferred to anti-mouse-IgG coated wells, together 
with additional bio-Mab dilutions (0.04 – 0.4 ng/µl), and incubated two hours with 
shaking. After the incubation the wells were washed with wash solution and the bound 
antibodies were detected using europium labelled anti-mouse-IgG. The portion of 
biotinylated antibodies were determined against a standard dilution prepared from the 
same biotinylated antibody. Concentrations of the antibody populations were deter-
mined using the Coomassie blue dye-binding assay (Bradford MM, 1976). 
3.3.2 Labelling with lanthanide chelates (I-IV) 
Intrinsically fluorescent 7-dentate (Takalo H, et al., 1994) or 9-dentate (von Lode P, et 
al., 2003b) europium (Eu) chelates containing amine reactive isothiocyanate moieties 
were used to label the monoclonal antibodies anti-hTSH Mab 5409 (Medix Bio-
chemica) (I) and cTnI specific Mab 8I7 (Spectral Diagnostics Inc., Canada) (II, IV) 
and Mab 7B9 (Hytest Ltd.) (II) and cTnI antigen (native human cardiac troponin I-T-C 
complex, from HyTest Ltd., Turku, Finland) (II). Europium chelate of 2,4-
(isothiocyanatobenzyl)di-ethylenetriaminetetra acetic acid (Mukkala VM, et al., 1989) 
was used to label the human TSH antigen (Scripps Laboratories, San Diego, CA) as 
described in I. For the labelling of the antibodies or antigens a suitable molar excess 
(10 – 35-fold) of the selected fluorescent label was dissolved in carbonate buffer (pH 
9.8) and reacted with the desired protein during an over night incubation at room tem-
perature or at 4 oC. The labelled proteins were purified using size-exclusion chroma-
tography. The labelling degree (i.e. Eu/protein ratio) was determined against a euro-
pium calibrator in DELFIA® enhancement solution (PerkinElmer Life and Analytical 
Sciences, Wallac Oy, Turku, Finland). The labelling degrees for monoclonal antibod-
ies were found to be 6 – 10 Eu / Mab. For labelled antigens a labelling degree of 1 – 2 
was determined. 
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3.3.3 Production and biotinylation of antibody fragments (I, II) 
TSH-specific monoclonal antibody cell line 5404 was cloned as a Fab fragment (Mw 
49 300 Da) and as an scFv fragment (Mw 28 200 Da) using standard procedure 
(Brockmann EC, et al., 2005). cTnI specific hybridoma cell lines 7F4 and 4C2 (Hytest 
Ltd.) were cloned as Fab fragments (Fab 7F4, Mw = 49.02 kDa, Fab 4C2, Mw = 47.8 
kDa) by reverse transcription PCR. The production of cTnI specific Fab fragments 
were performed as follows: Fab fragments were separately cloned into a pAK400 ex-
pression vectors (Krebber A, et al., 1997) containing a Cys-Pro-His6 coding sequence 
at the carboxyterminal end of the Fd chain providing a site for affinity purification and 
site-specific attachment of EZ-link maleimide PEO2-biotin (Pierce, Rockford, USA). 
The cells were grown in SB-medium containing 25 mg/l of antibiotic substance 
(chloramfenicol). When the cells reached a suitable optical density, the production of 
the Fab fragments were induced by adding 0.4 M isopropyl-β-D-
thiogalactopyranoside. After 4-8 hours from the induction, the cells were harvested by 
centrifugation and the Fab fragments were extracted form the periplasmic space of the 
Escherichia coli cells by Tris-Cl extraction based on osmotic shock. The purification 
of Fab fragments from the cell lysate was performed using cation exchange chroma-
tography (Streamline SP 25, GE Healthcare Bio-Sciences) followed by a more specific 
purification with a Ni-NTA superflow column (Qiagen, Venlo, The Netherlands). 
Finally the produced and purified Fab fragments were dialysed to PBS-buffer (10 mM 
NaHPO4 / NaH2PO4, 154 mM NaCl) and stored at 4 oC. The characterisation of the 
Fab fragments was performed with SDS-PAGE analysis run in PhastSystemTM elec-
trophoresis apparatus (GE Healthcare Bio-Sciences). The biotinylated Fab fragments 
were further characterised for portion of biotinylation using an in-house test described 
above (in the chapter 3.4.1) and for their antigen binding properties using Biacore X 
instrument (Biacore, Uppsala, Sweden). 
3.4 Characterisation of the solid phase properties 
3.4.1 Reporter molecules (III, IV) 
Biotin or biotinylated macromolecules (myoglobin or full-size antibody) containing 
Eu-chelate as detectable fluorescent label were used to monitor the surface binding 
capacity and surface binding density of the streptavidin coated wells (conventional 
microtitration wells and spot wells). A monoclonal antibody (αPSA H117) (Piironen 
T, et al., 1998) was used for determination of the surface binding capacities for a large 
molecule (Mw ≈ 160 000 Da), whereas myoglobin (horse skeletal muscle myoglobin 
from Sigma-Aldrich) represented a smaller macromolecule (Mw ≈ 117 000 Da). These 
reporter molecules were biotinylated with 80-fold molar excess of isothiocyanate 
modified biotin and labelled with 7-dentate fluorescent lanthanide chelate. The label-
ling degrees of these reporter molecules were adjusted to be approximately 1 – 2. The 
synthesis of the smallest reporter molecule (Eu-biotin), a modified biotin product of 4-
[2-(D-Biotinamido)-1-ethyl]phenylamine containing 7-dentate Eu chelate (Mw 1036 
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Da), has been previously described elsewhere (Välimaa L, et al., 2004), and it was 
used to monitor the surface binding densities and biotin binding capacities. 
3.4.2 Binding capacity of the streptavidin-coated surfaces for biotinylated reporter 
molecules (I-IV) 
For the characterisation of the binding efficiency of conventional immunoassay wells 
0.5-18 pmol of Eu-biotin or 0.5-90 pmol of biotinylated macromolecules were used, 
while 0.01-15 pmol of Eu-biotin or 0.1-60 pmol of biotinylated macromolecules were 
used for spot wells. The biotinylated and labelled molecules were diluted in the assay 
buffer (Assay solution, red) to the desired concentrations and immobilised on solid 
surface through streptavidin-biotin linkage. The immobilisation was performed at 
room temperature under shaking, followed by washing and drying steps. The fluores-
cence of the bound biotinylated molecule was first measured directly from the dried 
surface and after that upon dissociation of the fluorescent label to a homogeneous 
solution through DELFIA® enhancement. The surface readout measurement reflected 
the local surface binding density of the particular binding areas, whereas the DELFIA® 
enhancement represented an integrated signal from entire area and reflected the total 
binding capacity of the particular solid phase. 
3.4.3 Antigen binding features of immobilised antibodies (I, II, IV) 
Biotinylated anti-hTSH Mab clone 5404 (I), biotinylated recombinant Fab and scFv
fragments specific against hTSH (I), anti-cTnI Mab clones 7F4 and 4C2 (II) and bioti-
nylated recombinant anti-cTnI Fab fragments (II) were used to determine the antigen 
binding capacities of the streptavidin coated spot surfaces. In brief, the binding assays 
were performed as follows: biotinylated antibodies or antibody fragments were diluted 
in the assay buffer (Assay solution, red) prior to dosing into the streptavidin coated 
spot wells. Input amounts of 0.05–1.0 pmol per spot well for a Mab and 0.125–2.5 
pmol per spot well for antibody fragments were used. The immobilisation reactions of 
the biotinylated antibodies or antibody fragments onto the streptavidin coated surfaces 
were performed at room temperature (anti-hTSH antibodies) or at 35 oC (cTnI specific 
antibodies). After one hour incubation the wells were washed and 4-6 pmol of Eu-
hTSH or Eu-cTnI was added into the wells and incubated for additional 30-60 min-
utes. The fluorescence signal of the bound Eu-hTSH antigen was measured using Vic-
tor multilable counter (PerkinElmer Life and Anlytical Sciences – Wallac Oy) after 
DELFIA® enhancement. The 9-dentate Eu chelate of the labelled cTnI antigen enabled 
the fluorescent measurement to be performed directly from the dried well surface and 
thus additional enhancement step was not required. 
 
 
Summary of materials and methods 
 36
3.5 Solid-phase Immunoassays 
Several heterogeneous solid-phase immunoassays were performed to study the immu-
noassay performance in streptavidin coated surfaces. Briefly, the assays were con-
ducted by first immobilising the biotinylated capture antibodies or antibody Fab or 
scFv fragments onto a streptavidin coated polystyrene microtitration wells (conven-
tional wells or spot wells), followed by an incubation step with an analyte and a tracer 
antibody, which was labelled with intrinsically fluorescent europium chelate. Time-
resolved fluorescence measurement was performed either directly from the dried sur-
face or through DELFIA® enhancement. 
TSH immunoassays (I) 
TSH immunoassays on spot wells (and on conventional microtitration wells as refer-
ence assay) were performed either in a format of normal solution based assay design 
or utilising all-in-one dry chemistry technology (Lövgren T, et al., 1996). Capture 
antibody amounts of 0.2 – 1.0 pmol (for bio-Mab 5404), 0.5 – 1.25 pmol (for bio-Fab 
5404) and 0.8 – 2.0 pmol (for bio-scFv 5404) were used to achieve the immobilisation 
of the capture agents on spot surfaces through Sav-biotin linkage. On conventional 
microtitration wells coated with native streptavidin 2.8 pmol of Mab was immobilised. 
Eu-labelled anti-hTSH antibody 5409, recognising different epitope of hTSH than the 
capture antibodies (bio-Mab 5404, Bio-rFab 5404, Bio-rScFv 5404), was used as the 
tracer molecule for quantitative measurement of the bound analyte. 
cTnI immunoassays (II, IV) 
For cTnI immunoassays three different capture antibodies (clones 7F4, 4C2 and 
19C7), specific against different epitopes of cTnI (N-terminal, C-terminal or mid-
fragment epitopes) were immobilised on streptavidin coated spot surface to provide a 
binding surface for cTnI capturing. Eu-containing labelled antibody, which was spe-
cific either to cTnI (clone 8I7) or to cTnC (clone 7B9) was used as tracer molecule in 
different assay configurations. The fluorescent signal of the bound analyte-tracer 
complex was measured either directly from the dried binding surface and/or after 
DELFIA® enhancement. The cTnI immunoassays were conducted on spot wells either 
in mini well format or wells produced with contact printing technique, providing a 
spot-shaped binding are on a regular microtitration well surface. 
 







4 SUMMARY OF THE RESULTS AND DISCUSSION 
4.1 Characterisation of thiolated streaptvidin 
SATA is a versatile reagent which reacts with available amine groups in proteins via 
the NHS-ester end to form protected sulphydryl derivates. Amines that are located on 
the surface of the protein and are thus most accessible for conjugation are suggestively 
modified first while those that are in more buried positions are poorly available for 
conjugation. The primary targets for modification in streptavidin are the N-terminal α-
amines in the polypeptide chains and the NH2-groups (ε-amines) in the lysine side 
chains. The tetrameric streptavidin is composed of four identical monomeric sub-units, 
which each contains identical polypeptide chains with up to four lysine-residues pro-
viding the reactive ε-amines for conjugation. Thus, up to 16 ε-amines in the lysine 
side-chains plus four N-terminal α-amines of the polypeptide chains (i.e. totally 20 
amines), can be found in one tetrameric streptavidin, which are possible targets for 
conjugation reaction with SATA (Gitlin G, et al., 1988). 
Protein Data Bank files for streptavidin structures (entry 1SWQ, Figure 5) were re-
viewed to disclose the positions of lysines. Three of the four lysines (Lys121, Lys132 
and Lys134) found in each of the four sub-units of streptavidin are located on the sur-
face readily available for conjugation. The fourth lysine (Lys80) found in each of the 
protein sub-units are located in more buried positions. It was revealed that at least 70 
% of the possible target groups were activated in the conjugation reaction with excess 
of SATA during SH-Sav production, which is inline with the above mentioned obser-
vation about the amount of possible target groups. 
 
 
Figure 5. The three dimensional structure of 
streptavidin. The four identical sub-units are 
shown in different colours (purple, green, yel-
low and blue). Lysines (Lys80, Lys121, Lys132 
and Lys134) found in the surface of one sub-
unit are shown in red. The image was generated 
from the RCSB Protein Data Bank entry 1 SWQ 
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An average of 2 SH/Sav was found when 5-fold molar excess of SATA was used in 
the activation reaction and up to 12 SH/Sav was repeatedly measured when the activa-
tion reaction was conducted with 40 to 80 –fold molar excesses of SATA (Figure 6) 
(III). Thus the polymerisation level was correlated well with the activation degree (i.e. 
with the amount of thiols per Sav), which was measured directly after the SATA acti-
vation, using Ellman’s reaction. 
Figure 6. The binding densities of 
surface coated with the thiolated 
streptavidin (white columns) and 
level of sulphydryl incorporation 
(dotted line) of SH-Sav prepared 
with increasing concentrations of 
SATA reagent. SH-Sav was pre-
pared using four different molar 
excess (5-, 20-, 40 and 80-fold) of 
SATA. For reference, the binding 
capacity of native streptavidin (Sav) 
coating is shown (filled column). 
Saturated amount of Bio-Eu (90 
pmol/well) has been used. Fluores-
cence signals have been measured 
from dried surface, reflecting the 
local binding densities of the coated 
surfaces. (III) 
 
Gel filtration chromatograms of SH-Sav produced with different molar excesses of 
SATA revealed that when more thiol groups (measured with Ellman’s reaction) were 
incorporated to the streptavidin structure through the SATA activation, the polymeri-
sation level was increased providing larger protein complexes (Figure 7) (III). Corre-
sponding results were also obtained with SDS-PAGE analysis. Furthermore, it was 
shown that the formation of larger polymeric units was enhanced with increasing ex-
cess of SATA used for conjugation, while the proportion of the smaller monomeric 
units decreased. This reflects enhanced polymerisation through disulphide linkage 
formation achieved with increased excess of SATA. 
The chemical properties of SH-Sav were found to be different from that of the native 
SAv molecule. The positive charge of the amino-groups was neutralised by introduc-
ing more thiol residues to the Sav structure with higher excess of SATA, resulting in 
lower apparent pI-value (pI 3-5) of the protein, compared to native streptavidin (pI 
∼7). Thus the decrease in the pI-value of Sav after SATA treatment most likely derives 
from the formation of covalent amide bonds and thus leading to neutralization of the 
positively charged amines and the reduction in the protein net charge. The increased 
concentrations of negative thiol residues achieved by the deacetylation reaction also 
increases the negative charge of the SH-Sav, which causes further decrease in the pI-
value compared to the native protein.  







Figure 7. Gel filtration chroma-
tograms of polymerised strepta-
vidin molecules, produced by 
activating the native streptavidin 
with different molar excesses (5-, 





4.1.1 Adsorption properties of SH-Sav (III, unpublished) 
The change in pI had an influence on the adsorption behaviour of SH-Sav and thus it 
mainly contributed to the suitable coating buffer composition to obtain the best possi-
ble protein adsorption onto polystyrene. The most efficient adsorption of the thiolated 
streptavidin was observed at acidic pH region, where the net charge of the polymer 
was neutral. For comparison, the optimal coating condition for native streptavidin (pI 
7) is at pH 7 (unpublished). Adsorption of proteins to a solid surface is typically at 
maximum in the isoelectric region of the protein (Koutsoukos PG, et al., 1982). This is 
likely due to several reasons: the stability of a globular protein structure decreases 
with increasing net charge on the molecule, and hence structural changes are more 
likely to occur when proteins are adsorbed at a pH away from their isoelectric point. In 
contrast, at the isoelectric region the positive and negative charges of the protein are 
more or less evenly distributed over the molecule, resulting in intramolecular electro-
static attractions, which favours a compact structure, thus stabilising the molecule and 
leading to improved functionality when adsorbed. Furthermore, at the isoelectric 
point, where the protein net charge equals to zero, the proteins exhibit least lateral 
repulsion between the neighbouring proteins, thus facilitating the adsorption. (Norde 
W, 1986). 
The electrochemical interactions emerging between the solid surface and the protein to 
be adsorbed are one of the key driving forces behind the adsorption process. Thus one 
could expect that the protein adsorption on a solid surface is higher when the protein 
and surface are oppositely charged and that lower adsorption will be achieved with 
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equally charged patterns. This has been shown to be true in several studies (Ladam G, 
et al., 2002, Lubarsky GV, et al., 2005, Soltys-Robitaille CE, et al., 2001). However, 
some of the studies suggest that the surface charge does not influence the protein ad-
sorption efficiency at all (Blanco EM, et al., 2008, Ladam G, et al., 2002). Upon ad-
sorption process conformational changes of the protein may occur, which may lead to 
hydrophobic or hydrophilic forces becoming dominant interaction in the adsorption 
process independent of the surface charge. At pH 5.0 SH-Sav molecules carry a neu-
tral net charge, and thus it may be speculated that the adsorption of the polymerised 
SH-Sav molecules onto the amphiphilic polystyrene (Maxisorp) surface is mainly 
controlled by the intermolecular attraction forces (that is van der Waals interactions), 
rather than electrostatic interactions (that is covalent bonding or ionic bonds). Fur-
thermore, if the formation of the adsorbed layer of SH-Sav was mainly driven by elec-
trostatic interactions, it should be influenced by the ionic strength of the coating solu-
tion in contact with the solid phase. However, increase in the ionic strength of the SH-
Sav coating solution (achieved with sodium chloride addition) had only a minor effect 
on the adsorption efficiency of the SH-Sav coatings, supporting the statement that the 
main driving force in the SH-Sav adsorption is mainly intermolecular attraction forces, 
caused by the combined action of hydrogen bonding and hydrophobic interactions 
rather than the electrochemical interactions generated between the solid phase and the 
protein. 
It is widely known that larger proteins are more readily adsorbed compared to the 
smaller ones. The polymerisation of streptavidin molecules into larger units through 
SATA activation was, however, helpful to certain extent only. This was realised as the 
the size of the protein (SH-Sav) and thus the polymerisation level were found to in-
crease during the storage (Figure 8), but the binding capacity of the surface prepared 
from more extensively polymerised thiolated streptavidin was not further increased 
compared to the freshly prepared thiolated streptavidin when coated on polystyrene 
(unpublished). As the conjugation proceeded during the storage, the free thiol level 
(when measured with Ellman’s reaction) was decreased as they were consumed in the 
disulphide bridges (Figure 8, inserted graph). This indicates that the free thiol level did 
not have immediate effect on the adsorption of advanced polymers. However, to con-
trol the effect of the polymerisation, SH-Sav was kept and coated also under reducing 
conditions (DTT) where disulphide formation was inhibited. This resulted in slightly 
(but clearly) higher adsorption compared to Sav, indicating that the reactive thiols are 
somewhat helpful, for contacts between the protein and surface, either directly (con-
tacts between the thiols and surface) or indirectly (through polymerisation). 
The improved adsorption properties of SH-Sav were found to be related to the im-
proved adsorption kinetics of the protein onto the solid surface. Already after 15 min 
coating time with SH-Sav on polystyrene, equal binding capacity was obtained com-
pared to a reference SAv surface, which was prepared with over night incubation. 
Furthermore, the increase in the protein concentration in the coating solution was 
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found to contribute to faster coating process: increase of the SH-Sav amount from 0.5 
to 3 µg/well using 15 min coating time resulted up to 3.3-fold increase in the immobi-
lisation efficiency of the coated surfaces, although the same increase in the protein 
concentration with 20 hour coating time did not show any remarkable differences in 
the surface binding capacities. The gained improvement in the coating efficiency ob-
viously enables the production of streptavidin coated plates in shorter times, thus po-
tentially lowering the costs of the manufacturing process. 
 
Figure 8. Gel filtration 
chromatograms of SH-
Sav obtained after 24 
hours and 9 days (216 h) 
storage at 4 oC. As refer- 
ence an elution profile of 
native streptavidin is also 
shown. The inserted 
graph shows the change 
in the thiolation degrees 
(SH/Sav) during storage 
time, measured with the 
Ellman’s reaction. 
(modified from original 
publication III) 
 
4.1.2 Binding properties of the SH-Sav coatings (III, unpublished) 
The biotin binding capacities of the surfaces coated with thiolated streptavidin in-
creased after the excess of SATA used in modification (Figure 6). Based on this find-
ing it can be concluded that the formation of large polymeric units through the S-S-
linkage are mainly responsible for the improved binding properties achieved. In addi-
tion to the ability to bind small biotin, the surface ability to bind biotinylated mac-
romolecules was studied. These results are illustrated in the Figure 9. The Eu-derived 
fluorescence signals reached the saturation level after addition of 5 pmol of the bioti-
nylated macromolecule (myoglobin or monoclonal antibody) while addition of up to 
20 pmol of Eu-labelled small biotin was needed to reach the saturation level. The dif-
ferences in the saturation levels between small biotin and the biotinylated macromole-
cules on corresponding surfaces are derived from the steric hindrance evident for the 
macromolecules. Furthermore, the difference in the binding capacities between the 
native Sav coating and the SH-Sav coating derives from the improved surface binding 
density of the SH-Sav surface, as compared to the Sav surface. This was demonstrated 
by the surface readout measurement, which gave improved detectable signals on the 
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Figure 9. The binding efficiencies of 
the Sav and SH-Sav coated surfaces. 
Fluorescence signals of europium 
labelled biotin (A) or biotinylated 
macromolecules (myoglobin; Mb (B) 
and monoclonal antibody; Mab (C)) 
bound on SAv and SH-Sav coated 
surfaces are measured with Victor 
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4.1.3 Stability of the SH-Sav coatings (III) 
In addition to the improved biotin-binding properties of the SH-Sav surface, the sur-
face stability against desorption in solid-phase bioaffinity assay conditions was en-
hanced, compared to the reference Sav surface. The improved surface stability of the 
SH-Sav coating is most probably due to the covalent attachment of the Sav molecules 
into larger conjugates followed by the reduction in the amount of more readily disso-
ciating monomeric units. Adsorption of protein occurs in the first place through the 
sites present directly in the plastic surface. For uniformly assembled streptavidin 
monolayer the theoretical maximum adsorption capacity is 570 ng/well, but only 60 % 
of this has been experimentally reached with native streptavidin due to random assem-
bly (Välimaa L, et al., 2004). Typically, an excess of protein is added (like 1 µg / well 
/ 200 µl) and the generation of weakly bound secondary layers is evident. In the case 
of SH-Sav coatings the secondary layers are held by covalent bonds which contributes 
to the lower amount of proteins released during incubation and to the maintenance of 
the high binding properties of the surface. Furthermore, the surface coated with SH-
Sav was able to tolerate harsh conditions, such as addition of denaturing (such as gua-
nidine hydrochloride, urea and SDS) or reducing agents (such as TCEP or DTT). This 
property is highly valuable especially in applications utilising buffers or samples con-
taining surfactants or chaotropic agents. 
4.2 Performance of the spot coatings 
The high surface density gained with the modified streptavidin (SH-Sav and GA-Sav) 
coatings is a valuable characteristic especially in applications where the integrated 
signal of the bound tracer molecule is measured directly from a dry surface to assay 
very small and unsaturated amount of analytes. When the whole binding area of a 
capture solid phase is coinciding with the excitation beam of a measuring instrument, 
the change in detectable signals derived from the analyte binding can be more pre-
cisely observed providing improved detection limits for the particular assay. This has 
been previously shown to be true in the measurement of α-fetoprotein (Christopoulos 
TK, et al., 1990) and is probably most clearly exploited within the ambient analyte 
immunoassay concept represented by Ekins and co-workers in the early 1990s (Ekins 
RP, et al., 1991). Although the basis of the spot assay technology developed during 
this thesis work is different from that of the Ekins’s microspot theory (the spot assay 
being a normal reagent excess, “mass sensing” assay), the dependence of the assay 
performance on the reduced size of the coated area and on the capture surface density 
and binding activity of the immobilised antibodies to obtain improved detection limit 
is well demonstrated. 
4.2.1 Biotin binding capacity of spot surfaces in mini well format (I, II) 
Binding of biotinylated reporter molecules on the spot coated mini wells (used in the 
studies described in the original publications I and II) showed linear increase in bind-
ing followed by a rapid leave near to the saturation-level. Typical binding isotherms of 
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the spot wells are shown in the Figure 10. The fluorescence signal, when measured 
through the surface readout directly from the dried spot surface, showed lower detect-
able signals within subsaturating quantities of small Eu-biotin on the high capacity 
streptavidin surfaces (GA-Sav or SH-Sav), compared to surface made from unmodi-
fied streptavidin, although the difference between the coating types was clearly evi-
dent in the saturation region. This is derived from characteristics of the surface readout 
measuring technology. The imaging of the spot surfaces has previously disclosed  the 
uneven distribution of the bound Eu-labelled biotin onto the spot coatings, due to the 
liquid streams and high local velocities induced by the shaking motion during the 
binding steps (Välimaa L, et al., 2008). This was the main reason to gain lower detect-
able signal levels at the subsaturating quantities. It was further speculated that some 
lateral diffusion and clustering of the surface bound molecules may be relevant causes 
as well (Välimaa L, et al., 2008). 
The total biotin binding capacity was measured after dissociating the Eu ion of the 
fluorescent chelate into homogeneous solution through DELFIA® enhancement. The 
total binding capacity of the spot wells were increased with the increasing spot size 
(Figure 11, inserted graph). This is most likely derived from the increased capture area 
gained with the increasing spot size. Furthermore, the lower signal levels obtained at 
subsaturated levels in the surface readout measurement was not detected in the meas-
urement based on the dissociation enhancement, and rather identical signal levels were 
obtained with the Sav and high capacity surfaces already at the lower Eu-biotin input 
levels (unpublished). This further supports the argument stated by Välimaa et al. 
(2008) that the low signal detected at subsaturated levels are derived form the uneven 
distribution of the labelled analyte due to shaking mode, rather than irregular coating 






Figure 10. Binding iso-
therms of the Eu-biotin 
binding to the 2.5 mm spots 
coated with Sav or GA-Sav. 
Surface readout measure-
ment (dotted lines) and 
DELFIA® measurement 
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4.2.2 Antigen binding capacity of spot surfaces in mini well format (I, II) 
The intensity of Eu-derived fluorescence signals detected from the Eu-labelled hTSH 
antigen bound to streptavidin coated spot surfaces immobilised with biotinylated anti-
body, were increased when modified streptavidins and/or smaller site-directed bioti-
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Figure 11. Maximal antigen (hTSH) binding capacities of streptavidin (Sav) and high-capacity 
streptavidin (GA-Sav) coated spot-surfaces in mini-well format, immobilised with different 
biotinylated capture antibodies (Mab, Fab and scFv). The inserted graph shows the maximal 
biotin binding capacities of the native Sav, SH-Sav or GA-Sav coated spot surfaces, measured 
after DELFIA® enhancement. (I with  unpublished data) 
 
When chemically modified Sav (generated either by glutaraldehyde linkage or by 
SATA activation) was adsorbed onto the spot-shaped solid phase, the antigen binding 
capacity was improved up to 6-fold, compared to the native Sav coatings, depending 
on the spot size and the capture antibody format used. The utilisation of small anti-
body fragments on streptavidin coatings contributed more clearly to the improved 
antigen binding efficiency, compared to the utilisation of modified streptavidin coat-
ings. The gained improvement in the binding capacity of the surfaces utilising bioti-
nylated Fab or scFv fragments, instead of Mab, on Sav surface was up to 6.8–fold, 
while only 2 – 3-fold further improvement was gained with the GA-Sav surface im-
mobilised with corresponding biotinylated capture agents. 
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The increases in the antigen binding capacities along with the different coatings on 
spot surfaces are presented in the Table 3. The increase in the amount of bound anti-
gen along with the increasing spot size more likely originates from the larger binding 
surface, thus providing enhanced binding capacity. However, the increase in the bind-
ing capacity obtained on the modified streptavidin surfaces was not directly correlated 
with the coated surface area (and the spot size) and was slightly emphasised on the 
smaller (2.5 mm) spot surfaces, as compared to the larger spots (3.5 mm and 4.5 mm). 
One reason for the non-linear correlation of the antigen binding capacities between 
different spot surfaces could be the differences in the surface-to-volume ratios of dif-
ferent spot sizes. For 2.5 mm spot coatings (coating volume 4 µl, total surface area of 
6.5 mm2) the surface-to-volume ratio is 15.8 cm-1, while for the larger spots the corre-
sponding surface-to-volume ratio is ∼12 cm-1 (surface-to-volume ratios calculated for 
the area covering the bottom and the walls of the mini well indentation), providing 
shorter diffusion distance for the protein adsorption from the liquid onto the solid 
phase in the 2.5 mm spots, compared to the larger spots. On the Sav coatings the im-
provement in the binding capacities correlated well with the increasing surface areas. 
It is known that the adsorption behaviour of GA-Sav is different from the native Sav 
in coatings perfomed on regular microtitration wells (coating volume 200 µl, surface 
area 154 mm2) and more favourable adsorption in the bottom of the wells have been 
noticed for GA-Sav (Välimaa L, et al., 2003). This is likely true also in the case of 
SH-Sav molecules. The different coating practice of the spot production, compared to 
the conventional coating of regular microtitration wells, could add further discrepancy 
to the Sav and GA-Sav and/or SH-Sav adsorption behaviours. 
Table 3. Average improvement in antigen binding capacities obtained with spot-shaped bind-
ing surfaces utilising different streptavidin coatings and biotinylated capture molecules (full 
size antibody or antibody fragments). The average values presented (as X-fold compared to a 
reference surface) are calculated for the mini wells having diameter of 2.5 mm, 3.5 mm and 
4.5 mm.  











Sav Mab GA-SAv Mab 1.8 – 2.7 -fold 
Sav Fab GA-SAv Fab 1.7 – 2.9 -fold 
Sav scFv GA-SAv scFv 1.7 – 2.7 -fold 
Sav Mab Sav Fab 4.5 – 4.8 -fold 
Sav Mab Sav scFv 6.0 – 6.8 -fold 
GA-Sav Mab GA-SAv Fab 4.4 – 4.9 -fold 
GA-Sav Mab GA-SAv scFv 4.7 – 6.5 -fold 
 
Site-oriented attachment of the capture agents in solid-phase immunoassays has pro-
vided improvements in the overall assay performance (see Table 1 in the literature 
review section for examples). In this theses work site-specific biotinylation of recom-
binant antibody fragment was utilised to provide well oriented binding surface for 
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solid-phase spot assays. The functionality of the site-oriented attachments of the bioti-
nylated Fab and scFv were compared to the randomly biotinylated Mabs, to reveal the 
advantages involved in the site-oriented binding (I, II). The improvement in the anti-
gen binding efficiency of the streptavidin surfaces immobilised with biotinylated Fab 
or scFv fragments (shown in the Figure 11) are obviously derived from the dense 
functional binding surface formed through the site-oriented attachment of these frag-
ments to the streptavidin coatings. This was most clearly demonstrated with the bind-
ing of fluorescently labeled cTnI antigen on the streptavidin/capture antibody coat-
ings. The inherently fluorecent 9-dentate Eu-chelated used for the cTnI antigen label-
ing enabled the fluorescence signal to be measured directly form the dried spot sur-
face, thus reflecting the local antigen binding density, rather than the total antigen 
binding capacity of the measured surfaces. 
The antigen binding density of the immobilised Bio-Fab surface was up to 4.3 times 
higher than the corresponding values of the immobilised randomly biotinylated Mab 
surface (Figure 12). This indicates that the site-specifically biotinylated Fab fragments 
are more oriented upon the binding to the streptavidin coated polystyrene due to bio-
tin-Sav linkage. In addition to the direct orientation of the Fab-immobilised surface, 
the smaller size of the Fab fragments compared to the full-size Mab also facilitate the 





Figure 12. Antigen binding activi-
ties of site-specifically bioti-
nylated Fab fragment and ran-
domly biotinylated Mab as a func-
tion of surface coverage. Immobi-
lisation of the biotinylated capture 
agents (bio-Mab, bio-Fab) have 
been achieved through a stepta-
vidin coated polystyrene spot 
surface (mini well ∅ 3.5 mm). 
(Modified from the original publi-
cation II).  
 
The amount of antigen binding was significantly greater for the site-directed bioti-
nylated Fab on streptavidin surfaces at every antibody fragment surface coverage stud-
ied. However, it is important to note that while the antigen binding increased linearly 
up to a certain point (0.25 µg Fab input), further increase in the immobilisation 
amounts did not lead to significant improvement in the amount of antigen bound by 
the corresponding surface, indicating that the relative antigen binding efficiency of 
Sav-Bio-Fab surface decreases with surface coverage. This is most likely due to steric 
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proved the functional binding density (and thus the total binding capacity) of these 
surfaces, probably since more biotin-binding sites are available due to three dimen-
sional branched structure of the polymerised Savs formed through chemical linkage. 
4.2.3 Characteristics of the spot surfaces created on a planar surface (IV) 
The formulation of the spot-shaped binding surface on the bottom of a microtitration 
well through contact printing technique represented other approach for creating con-
dense binding surfaces compared to the spot wells manufactured in a mini well format. 
One of the advantages of the contact printing technique was associated to the manu-
facture point of view. The preparation of the spots in mini wells required a careful 
handling of the wells to avoid the breakage of the fragile liquid droplet placed in the 
moulded areas of the spot wells during processing and this was emphasised for larger 
spot sizes (especially for 4.5 mm). In addition, the uneven distribution of the reporter 
molecules in a bioaffinity assay, which was evident for the mini well approach, was 
avoided when spots were patterned on a planar surface instead of coating inside the 
mini wells. Although the patterned spot areas, produced through the contact printing, 
was not defined with any physical boundaries (like in the mini wells), the very small 
coating volume (still enabling sufficient binding characteristics) facilitated the han-
dling of the spot wells during processing. The surface binding area of 4.15 mm2 
achieved through the contact printing provided binding characteristics comparable to 
the conventional microtitration wells (154 mm2). 
The surface binding density of the bound Eu-biotin (when measured using surface 
readout) was found to be remarkably enhanced on the SH-Sav spots produced with 
additional betaine when compared to a reference streptavidin surface in a regular mi-
crotitration well (Figure 13). For some reason the spot coatings utilising native strep-
tavidin molecules and betaine in combination to the contact printing technique did not 
produce improved solid phase binding properties compared to the other coatings pre-
pared with native streptavidin. The improved binding densities of the SH-Sav/betaine 
surface enabled almost equal total binding capacities (when measured after DELFIA® 
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Figure 13. Surface binding ca-
pacities and surface densities of a 
reference Sav coated regular mi-
crotitration wells and contact 
printed spot wells coated with SH-
Sav. The main picture shows the 
signals of surface readout meas-
urement, reflecting the surface 
binding density. The inserted 
graph shows the fluorescence 
signals derived form the bound 
Eu-biotin after DELFA® en-
hancement, thus representing 
integrated signal from the whole 
binding surface. (unpublished) 
 
Betaines are amphoteric surfactants (zwitterionic), which at pH above 3 are present in 
their internally compensated betaine-like form and at pH below 1 are completely pro-
tonated showing properties of a cationic surfactant (Holmberg K, et al., 2003). Be-
taines have been utilised in many different industrial applications as well as in bio-
technology. Betaine has been for example found to improve the amplification reac-
tions in polymerase chain reactions (Miller GA, 1998). In this thesis study a betaine-
like compound of 2-trimethylammoniumacetate (also known as trimethylglycine or 
TMG) was applied in coatings at pH 5.0, where the zwitterionic form is expected to be 
predominant. The molecular structure of trimethylglycine is presented in the Figure 
14. 
 
Figure 14. Molecular structure of betaine monohydrate (2-trimethylammoniumacetate). 
 
SH-Sav spots were created using additional 1.5 M betaine in the coating solution. 
Based on the data by Diehl et al. (2001) this concentration has been found to be most 
suitable for the production of DNA microarrays on poly-L-lysine slides. They reported 
enhanced spot homogeneity and signal intensities at subsaturating analyte concentra-
tions with the addition of 1.5 M betaine, but no improvement in the total binding ca-
pacity was reported. The actual mechanisms related to the enhanced solid phase bind-
ing properties of the SH-Sav/betaine spots compared to a reference streptavidin sur-
face produced with the conventional methods remain somewhat unclear, although 
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efficiency is most likely the physical characteristics of betaine to reduce the evapora-
tion rate. At high concentrations betaine is known to increase viscosity and reduce 
evaporation, without affecting the surface tension (Diehl F, et al., 2001). During the 
course of evaporation betaine concentrates into the droplet until reaching a limiting 
value of 8 M, at which point the evaporation ceases (Diehl F, et al., 2001). By this 
way, the streptavidin molecules concentrate in the solution during spot formation and 
the immobilisation may thus become enhanced, providing improved biotin binding 
properties of the spot coatings. 
4.3 Immunoassays using spot surfaces 
To study the applicability of the spot-shaped solid surfaces for novel solid-phase im-
munoassays, two different biomarkers, thyroid stimulating hormone (TSH, thyrotro-
pin) and cardiac troponin I (cTnI), were applied as model analytes in spot assays. In 
the diagnosis of thyroid diseases TSH plays an important role being the primary bio-
marker of choice for the screening purposes when differentiation between the hypo-
thyroidism and hyperthyroidism is aimed (Dussault JH, et al., 1976, Kaplan MM, 
1999). The screening of neonatal hypothyroidism has in recent years been focused in 
the measurement of TSH (LePage J, et al., 2004, Spencer CA, et al., 1993) and there-
fore more sensitive assays for TSH analysis are needed, that provides quantitative 
measurements of TSH concentrations at very low levels (≤ 0.01 mU/l). 
4.3.1 TSH immunoassays on mini wells (I) 
The TSH assays conducted in the spot wells, described in the original publication I, 
reached assay detection limits of 0.002 – 0.006 mU/l, providing 4th generation assay 
sensitivity (Spencer CA, et al., 1993). Examples of dose-response curves of TSH im-
munoassays conducted on different solid phase binding surfaces utilised are presented 
in the Figure 15. 
 
Figure 15. Dose-response curves of 
the TSH immunoassay performed in 
a reference assay and in two differ-
ent spot assays. The reference assay 
is conducted on conventional micro-
titration wells, coated with native 
streptavidin and further immoblised 
with biotinylated Mab. The spot 
assays are conducted in streptavidin 
coated mini wells (∅ 2.5 mm) utilis-
ing either biotinylated full size anti-
body (Mab) or biotinylated Fab-
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The most sensitive THS immunoassay was obtained with the smallest spot area (mini 
well, diameter 2.5 mm), which was coated with native streptavidin and immobilised 
with the site-specifically biotinylated Fab fragments. The slopes of the dose-response 
curves for the spot-based assays, compared to a reference assay performed in conven-
tional microtitration wells, was increased providing up to 8-fold improvement in the 
detectable signal levels (Figure 15). Surprisingly, no further improvements in the as-
say sensitivity was gained with the high capacity streptavidin coatings (GA-Sav or 
SH-Sav) and, contrast to the expectations, lower signal intensities were obtained with 
these coatings, compared to the coatings produced with the native streptavidin. This is 
inconsistent with the data showing improved biotin binding capacity and antigen bind-
ing efficiency in high capacity coatings performed in larger spots (I). 
The reason for lower signal levels (when measured at surface readout) in larger high-
capacity spots, compared to smaller ones, in the TSH immunoassay measurements is 
largely originated from uneven distribution of the bound analyte on the capture surface 
and for this reason the measuring technology applied (surface readout) is not capable 
of reading the overall signal intensities derived from the total binding area. The total 
antigen binding capacity of these surfaces in a TSH assay was revealed after dissociat-
ing the bound fluorescent label of the capture antibody from the chelating structure to 
a homogeneous solution through the DELFIA® enhancement (Figure 16, unpublished).  
It was shown that increased signal intensities in DELFIA® enhancement were obtained 
with increasing surface capacity, which was contradictory to the results obtained with 
the surface readout measurements, but related to the actual total binding capacity of 
these surfaces. The mechanism behind this phenomenon has been previously dis-
cussed in more detail by Välimaa et al. (2008). They showed that the insufficient allo-
cation of the measuring beam within the surface readout to cover the surface binding 
area more than ∼5 mm2, contributed to the signal drop in surface readout with the high 
capacity binding surfaces of larger spots. The preferred binding of the captured com-
pounds to the edge of the spot area (due to incubation geometries and fluid dynamics) 
further facilitates the uneven distribution of the labelled molecules within the spot-
shaped binding areas. 
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Figure 16. The signal drop seen through the surface measurement (A) 
on larger spot areas (4.5 mm compared to 2.5mm) and on high capacity 
surfaces (GA-Sav compared to Sav) in TSH immunoassays is compen-
sated by DELFIA® measurement (B). TSH assays were conducted on 
2.5 mm or 4.5 mm spot wells in mini well format, coated with either Sav 
or GA-Sav and immobilised with biotinylted Mab or biotinylated Fab. 
In cTnI immunoassay (C) the signal levels were detected directly from 
the dried spot surfaces. cTnI assays were conducted in spots produced 
with contact printing technique, thus providing a smooth bindinig sur-
face without indentations. These spots were coated with either 
Sav/betaine or SH-SAv/betaine solution and immobilised with either 
biotinylated capture antibodies (Bio-Mab 19C7 and Bio-Mab 7F4; Mab 
assay) or with biotinylated Fab fragment (Bio-Fab 7F4; Fab assay). 
Note that the label molecules used in the TSH assay and in the cTnI 
assay are different and thus the signal levels represented in the figures 
(A) / (B) and (C) are not directly comparable. (Unpublished). 
 
4.3.2 cTnI immunoassays on spot surfaces (II, IV, unpublished) 
Low detection limits are prerequisite also for the measurement of cardiac troponins 
(including cTnI), which are released into blood circulation after necrosis of heart mus-
cle cells and are thus considered as highly specific biochemical marker of myocardial 
infarction (Katrukha AG, et al., 1997, Wu AH, et al., 1998). During this thesis work, 
different capture antibodies, individually or as in combination (each having specificity 
against different epitopes of cTnI antigen) were studied in the cTnI immunoassays, 
conducted in streptavidin coated 3.5 mm spot-wells, to obtain the best possible cTnI 
assay performance (II). The solid phase capture antibodies were used either in a form 
of randomly biotinylated Mab or site-oriented biotinylated Fab-fragment. It was 
shown that the utilisation of several capture antibodies, instead of a single capture 
antibody, provided improved signal intensities and enhanced assay sensitivity (Table 
4). Furthermore, the utilisation of the site-oriented attachment of the capture agents 
onto the solid surface provided further improvement in the surface binding capacity 
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in the binding affinities between the biotinylated Mab and Fab (revealed through 
Biacore analysis) most likely contributed to the obtained improvement in the overall 
performance of the cTnI assay when the site-specifically biotinylated Fab-fragments, 
instead of Mab, were used for capturing the analyte. The advantage of the smaller Fab 
fragments, over the full-size Mab, in solid phase coatings was not only limited to the 
obtained improvement in the detectable signal intensities providing assay sensitivity of 
0.002 µg/l, but also contributed to reduction of non-specific interference with the sam-
ple matrix (II). This feature is highly important in immunoassays utilising solid phase 
antibodies susceptible to negative or positive interference caused by the sample matrix 
(e.g. complement binding or interference caused by autoantibodies). The observed 
serum related interference with one of the capture Mab was only detectable when this 
particular Mab was used alone for capturing and the interference was not detected 
when combined with other antibodies or used as Fab fragment on the capture surface 
(II). Thus, the utilisation of more than one capture antibody, specific to different epi-
topes of the captured analyte can be highly recommended if the analyte is easily ex-
posed to proteolytic cleavage, being heterogeneous in structure, like that of cardiac 
troponins. 
Table 4. Detection limits of cTnI immunoassay performed in 3.5 mm spot coated microwells 
or in regular C-format microtitration wells. The assay numbering (#) corresponds to the num-
bering used in the original publication II. The represented detection limits are obtained from 
the experiments discussed in the original publication II and from additional unpublished data. 
 
Streptavidin 
Assay # Capture antibody Tracer antibody coating in spot wells in C12-wells
1 Mab 7F4a 8I7-Eu 1 native Sav 0.016 -
2 Mab 4C2b 8I7-Eu 1 native Sav 0.21 -
3 Mab 7F4a , Mab 4C2b 8I7-Eu 1 native Sav 0.003 0.011
3 Mab 7F4a, Mab 4C2b 8I7-Eu 1 SH-SAv 0.005 -
4 Mab 7F4a , Mab 4C2b , Mab 19C7c 7B9-Eu 2 native Sav 0.004 -
5 Fab 7F4a 8I7-Eu 1 native Sav 0.011 -
6 Fab 4C2b 8I7-Eu 1 native Sav 0.061 -
7 Fab 7F4a , Fab 4C2b 8I7-Eu 1 native Sav 0.002 0.007
7 Fab 7F4a , Fab 4C2b 8I7-Eu 1 SH-SAv 0.008 -
8 Fab 7F4a , Fab 4C2b , Mab 19C7c 7B9-Eu 2 native Sav 0.006 -
1  cTnI specific monoclonal antibody
2  cTnC specific monoclonal antibody
a  specificity against C-terminal epitopes of cTnI (a.a.r. 190-196)
b specificity against N-terminal epitopes of cTnI (a.a.r. 23-29)
c specificity against mid-fragent epitopes (a.a.r. 41-49)
* The detection limits correspond to the cTnI concentration calculated from 3-times of the standard deviation of the zero dose
Detection limit*  (µg/l)
 
In addition to the mini wells, spot surfaces prepared through contact printing were 
applied for cTnI immunoassays. This alternative approach for spot well manufacturing 
provided advanced properties for measuring technology point of view: contrary to the 
immunoassays conducted on mini wells, the signal levels measured with the surface 
readout measurement in cTnI immunoassays performed on spot surfaces produced 
with contact printing technique (thus providing a smooth binding surface without in-
dentation), showed signal levels consistent with the surface antigen binding capacity 
Summary of the results and discussion 
 54
(Figure 16, unpublished), and thus in these assays the inadequacy of the measuring 
technique to cover the whole binding area was eluded. The importance of adapting a 
proper measuring technology in particular assay design to obtain a substantial advan-
tage of the solid phase properties to the assay sensitivity was thus demonstrated. 
The cTnI immunoassay on contact printed spots utilising SH-SAv/betaine coating 
provided approximately 4-fold improvement in the specific signal levels compared to 
a reference assay performed on conventional microtitration wells with Sav coating 
(Figure 17). Furthermore a detection limit of 0.005 µg/l was obtained, providing a 2-
fold improvement in the assay sensitivity compared to a reference assay (DL = 0.01 
µg/l). Although the specific signal level were additionally 2-3–fold higher when bioti-
nylated Fab fragments (instead of Mab) were used on contact printed spots (utilising 
SH-SAv/betiane surface), no further improvement in the assay sensitivity was ob-
tained due to equal increase in the background signal levels. 
 
Figure 17. dose-response curves of 
cTnI immunoassays performed on 
conventional microtitration wells 
(squares) or on contact printed spots 
(filled squares). Mab 7F4 and Mab 
4C2 (reference) or Mab 7F4 and 
Mab 19C7 (contact printed spots) 
were used as capture antibodies on 
Sav surface (reference) or on SH-
SAv surface (spot). Eu-Mab 8I7 was 
used as tracer antibody. Fluores-
cence signal was measured from 
dried surfaces. The analytical detec-
tion limits were: 0.01 µg/l (for refer-
ence) and 0.005 µg/ml (for contact 
printed spots). (IV, Unpublished 
figure) 
 
4.3.3 Immunoassay kinetics (I, II) 
In solid-phase based assays the adsorption kinetics of the analyte binding to the solid 
capture surface is largely determined by the analyte concentration (mass transport and 
surface-to-volume ratio) and by the functional properties of the immobilised capture 
layer (Esser P, 1992b), and is further emphasised in miniaturised solid phases (Kusne-
zow W, et al., 2006). In the spot assays, the surface binding density and the dimen-
sions of the binding area correlated well with the obtained signal levels compared to 
the equilibrium signal at a given time-points, revealing enhanced kinetic behaviour 
with larger high-capacity spot coatings (I, II). By increasing the surface density of the 
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capture antibody layer in a spot surface, a 2–fold improvement in the assay kinetics (in 
terms of the ratio of the saturated signal level and the signal level reached at different 
time points) was obtained, compared to a regular Sav-Mab coating performed in an 
identical spot geometry (Figure 18). The use of a larger spot-shaped binding areas 
enabled further improvement in the assay kinetic due to the increased overall surface 
capacity. Although the kinetic of the spot assays was obviously slower compared to 
the kinetic behaviour observed in a conventional assay format (i.e. assays conducted in 
a regular C12-geometry microtitration well), improved signal intensities were already 
obtained at short incubation times (5 to 15 min). This enables potentially more sensi-
tive assay performance within short assay turnaround times (I, II). 
 
 
Figure 18. TSH immu-
noassay kinetics per-
formed in 2.5 mm spot 
surface, coated with 
native streptavidin (Sav) 
or with modified strepta-
vidin (SH-Sav) and im-
mobilised with bioti-
nylated monoclonal anti-
bodies (Mab) or antibody 
Fab fragments. The fluo-
rescence signal of the 
bound analyte-tracer 
complex was monitored 
at incubation times of 15, 












































The increasing knowledge of disease pathophysiology and clinical diagnostics has 
positioned new demands for the analytical techniques utilised for the detection of 
novel biomarkers. This has initiated the development of new tools in the technical 
field of bioaffinity assays and over the last decade the research in the diagnostic field 
has paid extensive attention on the miniaturisation of the bio-analytical systems (An-
genendt P, 2005). Miniaturisation of ligand-binding assays not only reduces costs by 
decreasing reagent consumption, but can simultaneously exceed the sensitivity of 
macroscopic techniques (Borrebaeck CA, 2000). Although the spot assay concept 
developed during this thesis work is not a truly miniaturised assay system in its actual 
meaning (the term miniaturisation refers mainly to systems encompassing devices and 
reaction vessels in a size of a micro- or nanoscale, for example microarrays or lab-on-
chip devices), the gained improvement in the assay sensitivity compared to a conven-
tional immunoassays performed in regular microtitration wells was clearly demon-
strated. The improvement in the detection limits obtained through the spot coatings are 
largely originated from the dense binding surface achieved through the modified strep-
tavidin coatings and site-oriented attachment of the antibody fragments to capture the 
analyte in a defined area coinciding with the excitation beam of the measuring instru-
ment. The obtained improvements in the solid phase characteristics of the developed 
spot surfaces would certainly provide enhanced assay properties also for the assay 
concept which are based on completely miniaturised systems. 
During this thesis study chemically modified streptavidin was used as the primary 
coatings on polystyrene surface to provide high-capacity functional binding surface 
for biotinylated capture molecules. The sandwich formation of the heterogeneous im-
munoassay, utilising site-specifically biotinylated antibody fragments on streptavidin 
coatings, was reduced to a size of a spot more closely coinciding with the excitation 
beam providing further improvement in the assay sensitivity. 
The main conclusions based on the original publications are: 
I The production of immunoassay wells by coating the streptavidin in a liquid 
droplet to provide a well-defined spot-shaped binding surface is a highly appli-
cable approach to improve the immunoassay performance in terms of assay sen-
sitivity. On the miniaturised binding surface the role of surface density becomes 
most critical for obtaining desirable assay functionality. It was shown that the 
increase in the binding surface density in a solid-phase immunoassay applied 
for quantitative measurements of biomolecules can be obtained by utilising 
highly dense binding area coinciding with the excitation beam of the measuring 
instrument in the surface readout. 
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II Utilisation of recombinant site-specifically oriented antibody Fab fragments as a 
solid phase binding agents in a cTnI immunoassay provides numerous advan-
tages over the full-size antibody. These include improved assay sensitivity and 
avoidance of sample matrix derived unwanted interference. Furhermore the im-
portance of applying several different capture antibodies immobilised onto a 
solid surface for capturing a highly heterogeneous analytes was highlighted. 
III The chemical modification of a native biomolecule is a highly applicable 
method to provide altered properties for immobilisation. The immobilisation ef-
ficiency of streptavidin can be improved by cross-linking the individual strepta-
vidin molecules into larger protein conjugates. By immobilising these polymer-
ised streptavidin molecules onto a polystyrene surface, enhanced binding capac-
ity (up to 2–fold) for biotinylated molecules can be obtained. Furthermore, for-
mation of highly bridged surface structures achieved by the cross-linked strep-
tavidin coatings clearly improves the surface stability in terms of protein de-
sorption as well as the surface tolerability against harsh chemical conditions, 
such as denaturing conditions. The degree of cross-linking (i.e. the size of the 
formed streptavidin polymers) highly determines the immobilisation efficiency 
and surface stability. 
IV Spot-shaped binding surface produced on the bottom of a conventional microti-
tration well through contact printing is a useful approach for spot-well produc-
tion. The planar surface created through the contact printing technique enables 
spot-shaped binding surfaces, which are highly applicable for surface readout 
measurements. With the optimised coating buffer composition remarkable im-
provement (18-fold) in the biotin binding density was obtained with the contact 
printed spots, compared to a reference surface prepared with native streptavidin 
on conventional microtitration wells. This enabled almost equal total biotin 
binding capacities when the 4.2 mm2 spot surface was compared with the sur-
face area of 154 mm2 conventional microtitration wells. 
In short conclusion, the dense and oriented binding surface, with the combination of 
spot assay design and surface measurement approach is a well suitable technology to 
be applied in solid-phase immunoassays to gain improved solid phase performance in 
terms of assay sensitivity and kinetics, characteristics that are very useful to improve 
the immunoassay performance of further point-of care assays. The utilisation of cross-
linked streptavidin molecules adsorbed onto a polystyrene surface, in combination 
with the site-specifically biotinylated antibodies or antibody fragments and spot coat-
ing technology enables the production of highly functional solid phases capable for 
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